willdate
Funding round closes in support of ConKay annuloplasty system for TR treatment
ConKay Medical Systems, a medtech start-up company developing a device for treating patients sufferi...
Global Cardiovascular Awards – The full list of winners and highly commended entries
Best Cardiovascular Product Launch– Siemens Healthineers: ARTIS Family
Best Medical Educati...
Past, present and future of cardiovascular innovation celebrated at Global Cardiovascular Awards
A founding father of transcatheter aortic valve implantation (TAVI), professor Alain Cribier (Un...
Cost-effectiveness and updated efficacy data from Evolut Low Risk trial shared at CRT 2024
Medtronic has announced two late-breaking data presentations on four-year outcomes from the Evol...
Gilbert Tang named as editor-in-chief of JACC: Case Reports
Cardiothoracic surgeon Gilbert Tang (Mount Sinai Health System, New York, USA) has been named ed...
Customising PCI with DES and DCB
This educational supplement, sponsored by Medtronic, explores the latest thinking around percutaneou...
ADVERTORIAL: TAVI offers promise in the “underdiagnosed and undertreated” aortic regurgitation population
This advertorial is sponsored by JenaValve
Transcatheter aortic valve implantation (TAVI) has...
HeartFlow shares ten-year data from DISCOVER-FLOW study
HeartFlow has announced that 10-year follow-up data from its DISCOVER-FLOW study were published ...
First mitral valve replacement performed using SSi Mantra robotic system
SS Innovations International has announced that surgeons have performed the world’s first mitral val...
CRT 2024: SAFE-MCS finds reduction in bleeding for high-risk PCI patients with bleed monitoring system
Saranas has announced results of SAFE-MCS, a multicentre clinical study evaluating the safety of com...
CRT 2024: New data on outcomes with Sapien TAVI platform
Results from two large, real-world studies assessing outcomes for patients undergoing transcathe...
US FDA approves weight loss drug Wegovy to prevent cardiovascular events
The US Food and Drug Administration (FDA) has approved an additional indication for the weight l...
PulseCath’s iVAC 2L gains MDR certification
PulseCath has announced the transition from CE marking to EU Medical Device Regulation (MDR) certifi...
Cleerly receives US FDA breakthrough designation for CAD staging system
Cleerly has been granted breakthrough device designation by the US Food and Drug Administration (FDA...
PROACTIVE-HF pivotal trial of Cordella pulmonary artery sensor meets primary endpoints
Six-month results from the PROACTIVE-HF pivotal trial, evaluating the Cordella pulmonary artery ...
Trial of autologous cell therapy in advanced chronic heart failure reports interim results at THT 2024
BioCardia has announced interim results from the phase III randomised controlled trial of its CardiA...
FastWave Medical gains third patent from USPTO for IVL system
FastWave Medical has announced the issuance of its third utility patent by the US Patent and Tradema...
Mobile clinical research specialist Hawthorne Effect appoints new CEO
Hawthorne Effect, a specialist in technology-enabled mobile clinical research, announced the app...
Boston Scientific’s Agent DCB gains first US FDA coronary approval
Boston Scientific has announced that it has received US Food and Drug Administration (FDA) approval ...
EACTS and STS guidelines recognise aorta “as an organ in its own right”
New guidelines from the European Association for Cardio-Thoracic Surgery (EACTS) and the Society...
Patient enrolment completed in study of remote heart failure monitoring device
FIRE1 today announced that it has completed patient enrolment in the US early feasibility study—FUTU...
First patient treated using A-Flux Reducer interventional system for angina
VahatiCor has announced the treatment of the first patient with the A-Flux Reducer system, an in...
Renal denervation finds new shores following US FDA device approvals
Like London buses, interventionalists have had a long wait for the US Food and Drug Administrati...
Settling the paclitaxel versus sirolimus DCB debate
Bernardo Cortese (Fondazione Ricerca e Innovazione Cardiovascolare, Lodi, Italy and DCB Academy) has...
Challenges establishing minimally invasive cardiac surgery in the developing world
Attaulah Khan Niazi (King Edward Medical University, Lahore, Pakistan) documents the major challenge...
Foldax agrees manufacturing agreement with Dolphin Life Science India
Foldax has announced a manufacturing agreement with Dolphin Life Science India to enable in-coun...
First cases using Laminar LAAX system performed as part of IDE study
Biosense Webster has announced the commencement of patient cases with the investigational Laminar le...
Ismail El-Hamamsy named as president of Heart Valve Society
Ismail El-Hamamsy, director of aortic surgery for the Mount Sinai Health System (New York, USA),...
First procedure completed using Laplace tricuspid valve replacement system
Laplace Interventional has announced the successful completion of its first-in-human (FIH) proce...
Cardiovascular News – Issue 72 – February 2024: OUS Edition
In this issue:
New data point to shift towards TAVI in patients aged under 60
ORBITA-2 trial...
Cardiovascular News – Issue 72 – February 2024: US Edition
In this issue:
New data point to shift towards TAVI in patients aged under 60
ORBITA-2 trial...
Todd Berg joins NeoChord as CEO
NeoChord has appointed Todd Berg as chief executive officer to oversee clinical and commercial prog...
Ajay Kirtane
For Ajay Kirtane (Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York,...
Analyses provide “hard evidence” of benefit of intravascular imaging-guided PCI
Two meta-analyses comparing the use of intravascular imaging to angiography for the guidance of ...
Australian government offers grant support to artificial heart programme
BiVACOR, a clinical-stage medical device company, has announced that US$13 million has been awarded ...
Reprieve Cardiovascular secures multimillion dollar financing
Reprieve Cardiovascular, a development stage company focused on pioneering an automated diuretic and...
Global registry charts pandemic’s impact on TAVI volumes
Transcatheter aortic valve implantation (TAVI) procedures were more acutely impacted during the ...
Alain Cribier: 1945–2024
Alain Cribier, the pioneering cardiologist who performed the world’s first transcatheter aortic ...
TriClip gets positive vote from US FDA advisory panel
The Circulatory System Devices Panel of the Medical Devices Advisory Committee for the US Food and D...
Biotronik’s Freesolve resorbable magnesium scaffold gains CE mark
Biotronik has announced the CE approval and launch of the Freesolve resorbable magnesium scaffold (R...
BHF PROTECT-TAVI trial poised to answer key questions about use of cerebral embolic protection during TAVI
Investigators behind the largest randomised trial to date to assess the use of cerebral embolic ...
FLOWer embolic protection device gains CE mark
AorticLab has announced CE mark certification for the FLOWer transcatether embolic protection device...
Biotronik launches Micro RX microcatheter to the US market
Biotronik has launched the Micro Rx novel rapid exchange microcatheter to enhance guidewire support ...
Study of TIVUS renal denervation system for hypertension treatment completes enrolment
The REDUCED-1 study, a US Food and Drug Administration (FDA) investigational device exemption (IDE)-...
Health Canada approves VenusP-Valve transcatheter pulmonic valve replacement system
Venus Medtech has announced that the VenusP-Valve transcatheter pulmonic valve replacement (TPVR) sy...
Early feasibility study of TAVI platform for treatment of aortic regurgitation completes enrolment
Genesis MedTech has announced the completion of enrolment in its US early feasibility study (EFS) us...
STS 2024: Large registry study demonstrates superiority of multi-arterial grafting for multivessel revascularisation
A study of more than one million patients undergoing isolated coronary artery bypass graft (CABG...
Evoque becomes first transcatheter tricuspid system to gain US FDA approval
Edwards Lifesciences has announced that its Evoque tricuspid valve replacement system is the fir...
AF Symposium 2024: AI-enabled predictive pre-planning “significantly improves LAAO procedural efficiency”
Data from the first US comprehensive single-centre experience at St Bernard’s Medical Center and Arr...
Cast your vote for the Heart Team of the Year
Two specialist heart teams are vying to win the Heart Team of the Year Award at the first Global Car...
SCAI publishes expert consensus statement on calcified coronary lesions
A newly published Society for Cardiovascular Angiography and Interventions (SCAI) expert consens...
Philips’ “mini” 3D TEE transducer granted US FDA approval
Royal Philips has received US Food and Drug Administration (FDA) 510(k) clearance for its X11-4t tra...
STS 2024: STS elects its first female president
Jennifer C Romano has been named president of the Society of Thoracic Surgeons (STS), the first ...
STS 2024: Data show shift in the proportion of patients under 60 receiving TAVI instead of SAVR
Research presented at the 60th annual meeting of the Society of Thoracic Surgeons (STS 2024; 27–...
French registry study finds fewer cardiovascular deaths among mitral regurgitation patients receiving TEER
The results of a propensity-matched analysis of all patients undergoing mitral valve surgery or tran...
Early feasibility study of CroíValve’s Duo tricuspid coaptation valve system launches
CroíValve has announced the initiation of its early feasibility study (EFS) for the Duo tricuspid co...
Collaboration aims to develop a bespoke cell phenotyping assay for human blood
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coro...
Three valve-in-valve procedures completed using DurAVR transcatheter valve
Anteris Technologies has announced the successful completion of three new valve-in-valve (ViV) cases...
US FDA grants breakthrough designation for Pi-Cardia’s ShortCut leaflet splitting device
Pi-Cardia has received breakthrough device designation from the US Food and Drug Administration (FDA...
See the full shortlist for the Global Cardiovascular Awards
The full shortlist for the inaugural Global Cardiovascular Awards—which will recognise the tireless ...
First-in-human implant of Triflo heart valve completed
Novostia has announced the successful first-in-human implantation of its Triflo aortic valve.
The...
Radiofrequency renal denervation meets cost efficiency threshold in value analysis
An analysis of data from the SPYRAL HTN-ON MED trial of the Symplicity Spyral (Medtronic) radiof...
FastWave Medical announces completion of first procedures in study of novel peripheral IVL system
FastWave Medical has announced the successful completion of enrolment for its first-in-human (FI...
Study shows no safety risk in allowing patients to eat prior to cardiac catherisation
Allowing patients to eat before elective cardiac catheterisation posed no safety risk and benefited ...
“Structural heart leader” joins Cardiac Dimensions as chief medical officer
Cardiac Dimensions, a developer of invasive treatment modalities to address patients suffering f...
Penumbra launches Indigo system CAT RX catheter in Europe to treat acute coronary syndrome
Penumbra has secured CE mark for its Indigo system CAT RX designed to address the limitations of tra...
Occlutech to launch atrial septal defect occluder in the USA
Occlutech has announced that the US Food and Drug Administration (FDA) has approved the Occlutech AS...
US FDA grants clearance for VR surgical planning software from Realize Medical
Realize Medical has announced that its virtual reality (VR) software for surgical planning, Elucis, ...
First patient randomised in BACKBEAT study of AVIM therapy for uncontrolled hypertension
Orchestra BioMed Holdings has announced the first patient was randomised in the BACKBEAT pivotal stu...
US FDA approves ENGULF US pivotal trial of Hēlo thrombectomy system
Endovascular Engineering (E2) has announced US Food and Drug Administration (FDA) investigational de...
Medical cannabis for chronic pain may increase risk of arrhythmia
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, ac...
GE HealthCare to acquire AI-imaging specialist
GE HealthCare has entered into an agreement to acquire MIM Software, a provider of artificial intell...
R-One robotic platform given green light to enter Chinese market
Robocath has announced the granting of a marketing authorisation to distribute its R-One robotic pla...
Endotronix submits premarket approval application to US FDA for Cordella pulmonary artery sensor
Endotronix has submitted a premarket approval (PMA) application for its Cordella pulmonary arter...
Edwards Lifesciences appoints its first US case observation site under Benchmark TAVI programme
Eisenhower Health (Rancho Mirage, USA) is the first hospital in the USA to become an Edwards Ben...
Topaz tricuspid valve replacement system used for the first time in a patient with a pacemaker
TRiCares SAS has announced the successful implantation of its Topaz transfemoral tricuspid heart val...
Chilean centre treats five aortic regurgitation patients in a single day with Zeta TAVI system
Laguna Tech USA has announced that a record number five patients were successfully treated at a sing...
HeartFlow’s FFRCT analysis passes 250,000 patient milestone
HeartFlow, a developer of non-invasive artificial intelligence (AI) precision coronary care solu...
Pulse Biosciences files premarket US FDA 510(k) notification for its CellFX nsPFA cardiac clamp
Pulse Biosciences has filed a premarket notification 510(k) to the US Food and Drug Administration (...
Investors offer backing for developer of transcatheter mitral chord repair technology
Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally de...
First patient treated in ARISE II study of Gore ascending stent graft
Gore has announced the first patient implantation of the Gore ascending stent graft in the ARISE II ...
Cardiovascular News’ top stories of 2023
Which stories, features and interviews captured the attention of the cardiovascular community across...
Blood potassium monitor under development to benefit patients with chronic renal failure
CardioRenal and CHU Grenoble Alpes have announced an innovation that allows chronically ill patients...
LUMA Vision secures US$22 million in financing
LUMA Vision, developer of a novel four-dimensional (4D) cardiac imaging and navigation platform,...
CE mark trial of Optimum TAVI valve given green light for expansion
Thubrikar Aortic Valve has received authorisation from the Competent Authority of Poland to expand t...
Microbot Medical and Corewell Health announce telerobotics collaboration
Microbot Medical, developer of the Liberty endovascular robotic surgical system, has entered into a ...
Early use of mechanical support shows benefit for patients with AMI complicated by cardiogenic shock
Results of the National Cardiogenic Shock Initiative—a single-arm multicentre study assessing the fe...
ANGIODAPT trial launches with first patient enrolment
iVascular has announced the initiation of its first randomised trial of an abbreviated dual antiplat...
First-in-man cross-country robotic coronary angioplasty performed in two Chinese centres
Robocath has announced a first-in-human robotic coronary angioplasty performed at a distance of 1,70...
First patient treated with PerQseal Elite vascular closure system
Vivasure Medical has announced the first patient treated with PerQseal Elite, the latest generation ...
Haemonetics completes acquisition of OpSens
Haemonetics Corporation has completed its acquisition of OpSens, the company announced in a press re...
Consortium to assess use of CT to improve diagnosis and treatment of coronary artery disease
A public-private partnership, involving input from clinical and industry partners, will investigate ...
Mortality from cardiovascular disease continues to increase globally
Cardiovascular diseases, including ischaemic heart disease, stroke, heart failure, peripheral and ao...
Pi-Cardia appoints Gary Gratson to lead commercialisation of ShortCut
Pi-Cardia has appointed Gary Gratson to lead commercial operations for ShortCut, its dedicated l...
Warfarin lowers mortality risk after SAVR
Patients who received warfarin after bioprosthetic aortic valve replacement had lower incidence of m...
Harlan M Krumholz named as JACC editor-in-chief
The cardiologist and researcher, Harlan M Krumholz (Yale School of Medicine, New Haven, USA), ha...
Projected rise in aortic valve-in-valve procedures prompts interest in leaflet splitting device
Details of the first pivotal trial assessing the use of a dedicated leaflet splitting device to ...
Catheter Precision’s VIVO 3D mapping system secures reimbursement in NHS England’s SSDP
Healthcare 21 (HC21) has gained national reimbursement for Catheter Precision’s VIVO 3D mapping syst...
Kaneka Corporation acquires Japan Medical Device Technology Co
Kaneka Corporation has acquired all shares of Japan Medical Device Technology Co and has made it a w...
Profiling plaque to guide treatment of coronary artery disease
Investigators behind the BIOPATTERN trial hope that their work will shape the understanding of w...
Carmat increases capacity with opening of second production facility
Carmat has opened a second production facility in Bois-d'Arcy.
Works on the site, which is in the...
Medtronic launches Penditure left atrial appendage exclusion system in the USA
Medtronic has announced the launch of its Penditure left atrial appendage (LAA) exclusion system...
First patients join pivotal trial of Aortix pump for treatment of acute decompensated heart failure
Procyrion has announced the enrolment of the first patients in the company’s investigational dev...
Johnson & Johnson acquires Laminar
Johnson & Johnson MedTech has announced the completion of the acquisition of Laminar, a medical ...
Next-generation Palmetto TMVR system gets first-in-man use
ReValve Solutions has announced the successful first-in-human use of its Palmetto transcatheter mitr...
Bivacor gets US FDA nod for early feasibility of its total artificial heart
The US Food and Drug Administration (FDA) has given the green light for commencement of an investiga...
BIOPATTERN trial seeks precision approach to coronary artery disease treatment
PlaqueTec has received approval from UK’s Medicines and Healthcare products Regulatory Agency (M...
Enrolment in Indian clinical trial of Tria mitral valve completed
Foldax has announced completion of enrolment in the Indian clinical trial of the TRIA polymer su...
First patient enrolled in RECOVER IV randomised trial of Impella in AMI patients
Abiomed has announced that the first patient in the world has been enrolled in the landmark RECOVER ...
AF after mitral valve surgery “has a strong negative influence on survival”
The occurrence of atrial fibrillation (AF) after mitral valve surgery may be more harmful than previ...
EACTS panel sounds call to action over sex disparities in coronary surgery
A historic underrepresentation of women in clinical trials for coronary artery bypass graft (CAB...
Low-risk TAVI trials underscore optimism for transcatheter approach but surgical societies reserve caution
“It has been a good day for TAVI ,” commented Raj Makkar (Cedars-Sinai, Los Angeles, USA) at thi...
Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ
A comparison of two latest-generation self-expanding and balloon-expandable transcatheter aortic...
AI-derived risk score may improve planning of TEER for secondary mitral regurgitation
A novel risk score derived from artificial intelligence (AI) may be more effective than currentl...
SCAI: First US renal denervation approvals “revolutionise” treatment of uncontrolled hypertension
The approval of two renal denervation devices by the US Food and Drug Administration (FDA)—the Parad...
Supira Medical to initiate US clinical programme for pVAD system
Supira Medical announced today that it has received US Food and Drug Administration (FDA) breakt...
Roadmap launched to guide shared decision-making in heart valve disease treatment
Global Heart Hub, an international alliance of heart patient organisations, has published an impleme...
Medtronic’s Symplicity Spyral renal denervation system granted US FDA approval for hypertension treatment
Medtronic has announced approval from the US Food and Drug Administration (FDA) for the Symplicity S...
JenaValve partners with American Society of Echocardiography to increase awareness of aortic regurgitation
JenaValve Technology has announced that it will join the American Society of Echocardiography (ASE) ...
ADVERTORIAL: NOTION trial results crystallise long-term thinking on TAVI versus SAVR
This advertorial is sponsored by Medtronic
With transcatheter aortic valve implantation (TAVI...
Jolanda Kluin
Inspired by a passion for nature, Jolanda Kluin began her career in medicine in Africa, before retur...
Cardiovascular News – Issue 71 – November 2023: OUS Edition
In this issue:
Low-risk TAVI trials spark optimism, but surgical societies urge caution over a ...
Cardiovascular News – Issue 71 – November 2023: US Edition
In this issue:
Low-risk TAVI trials spark optimism, but surgical societies urge caution over a ...
ARIES trial shows LVAD patients who did not receive aspirin had fewer bleeding complications
Abbott has announced new late-breaking data that show advanced heart failure patients living wit...
ACCESS-MANTA registry to assess use of Manta vascular closure device in TAVI procedures
Teleflex has announced the first patient enrolment in a clinical registry that is intended to examin...
TRANSFORM trial to explore personalised strategy for cardiovascular disease prevention
Cleerly has announced the TRANSFORM trial a randomised trial that aims to enroll 7,500 patients ...
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and thos...
First-in-human study explores safety and feasibility of Captis embolic protection device during TAVI procedures
Filterlex Medical has announced the publication of a first-in-human (FIH) study EuroIntervention...
EECP therapy results “promising” for ANOCA patients
Enhanced external counterpulsation (EECP, Flow Therapy), a non-invasive treatment that increases...
PATCH clinical study of PerQseal vascular closure system reaches 100-patient milestone
Vivasure Medical has enrolled the 100th patient in its PATCH clinical study, a multicentre, sing...
First-in-human results of non-invasive ultrasound therapy for aortic stenosis published in The Lancet
Results from first-in-human (FIH) clinical studies on 40 patients suffering from calcific aortic ste...
First implant of ChordArt TMVR system completed
CoreMedic has announced the first successful application of its ChordArt transcatheter technology fo...
AHA 2023: RCE Technologies wins Health Tech competition
RCE Technologies, the developer of a non-invasive, instant measurement of cardiac proteins was s...
SELECT trial shows cardiovascular risk reduction in non-diabetics taking semaglutide
Results of the SELECT clinical trial, presented at the American Heart Association’s 2023 Scientific ...
Xenter unveils dual-sensor TAVI guidewire
Xenter unveiled its dual sensor investigational guidewire for transcatheter aortic valve implantatio...
PCI improves angina symptoms without medication in ORBITA-2 trial
Percutaneous coronary intervention (PCI) relieves stable chest pain and improves exercise capaci...
Data and debate to bring new light to aortic controversies at CX 2024
The aortic programme at the 2024 Charing Cross (CX) Symposium (23–25 April, London, UK) promises to ...
Medinbox launches latest proctoring and remote learning platform for cath labs
Medinbox has launched its latest product suites to enhance live collaboration for medical educat...
Scott Drake appointed as Cordis CEO
Cordis has announced that its board of directors has appointed Scott Drake as chief executive of...
Recor Medical gains first US FDA renal denervation approval
Recor Medical has become the first company in the USA to have a device-based therapy approved fo...
CONFORMAL EFS results shared out to one year at TCT 2023
Conformal Medical has announced positive one-year results from the company's CONFORMAL Early Fea...
No difference in outcomes for AF patients undergoing LAAO and TAVI at the same time
Patients with atrial fibrillation (AF) undergoing a transcatheter aortic valve implantation (TAV...
E2 shares positive initial results from use of Hēlo system for acute sub-massive pulmonary embolism treatment
Endovascular Engineering (E2) has announced positive initial results from its ENGULF study, demonstr...
First patients enrolled in coronary de novo trial of Selution SLR drug-eluting balloon
Cordis has announced enrolment of the first patient in its SELUTION4DeNovo IDE trial, the coronary d...
TCT 2023: TAVI system for aortic regurgitation shows promise in ALIGN AR trial
Positive results from the ALIGN AR pivotal trial, investigating the use of the Trilogy (JenaValv...
First patients treated with Laguna Tech’s Alpha and Zeta aortic valves
Laguna Tech USA has announced that the first-in-human clinical case was completed with the Zeta ball...
Edwards Lifesciences’ Mitris Resilia valve receives CE mark for mitral replacement surgeries
Edwards Lifesciences has received CE mark for the Mitris Resilia tissue valve replacement specifical...
TCT 2023: TRILUMINATE quality of life data point to benefit for patients with severe TR undergoing TEER
Analysis of health status and quality of life data from the TRILUMINATE Pivotal trial, presented...
TCT 2023: Initial phase of TRISCEND II trial of Evoque transcatheter replacement for severe tricuspid regurgitation meets primary endpoints
A randomised trial comparing transcatheter tricuspid valve replacement (TTVR) with the Evoque sy...
TCT 2023: Agent DCB shows superiority to conventional balloon angioplasty for target-lesion failure in US randomised trial
The first US randomised trial investigating the safety and efficacy on the use of a drug-coated ...
TCT 2023: Five-year PARTNER 3 results “reaffirm” role of TAVI as alternative to surgery in low-risk patients
Five-year data from the PARTNER 3 trial, which randomised low surgical risk aortic stenosis pati...
TCT 2023: Intellistent multi-lumen stent system for pulmonary arterial hypertension wins Shark Tank innovation prize
HeartPoint Global was named winner in the Shark Tank Innovation Competition at the 2023 TCT conferen...
Medinol’s EluNIR-PERL coronary stent gains US FDA approval
Medinol today announced US Food and Drug Administration (FDA) approval for the EluNIR-PERL drug-...
TCT 2023: EVOLUT Low Risk trial shows continued strong performance for self-expanding TAVI platform out to four years
At four years of follow-up, patients with severe aortic stenosis at low risk for surgery undergo...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped sway the US FDA
Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) ...
GE HealthCare’s Allia IGS Pulse imaging system approved by the US FDA
GE HealthCare has announced US Food and Drug Administration (FDA) 510(k) clearance of Allia IGS Puls...
RELIEF clinical study of PFO closure for migraine relief begins randomisation
Patients have passed through the multi-month enhanced screening process and have begun entering ...
Multicentre study points to favourable safety and efficacy of radial access for peripheral interventions
New research examining the safety and efficacy of using radial access for peripheral artery inte...
Site-less model helps to improve diversity in PREVUE-VALVE study
Researchers behind a trial to quantify the true prevalence of valvular heart disease within the USA ...
Medtronic receives CE mark for Evolut FX TAVI system to treat severe aortic stenosis
Medtronic has received CE mark for the Evolut FX transcatheter aortic valve implantation (TAVI) syst...
EACTS 2023: Registry study finds “significantly increased” all-cause mortality among older patients selected for TAVI versus SAVR
A population-based cohort study of patients treated in the Austrian healthcare system has found ...
OpSens and Haemonetics enter into acquisition agreement
OpSens has entered into a definitive arrangement agreement with Haemonetics Corporation that will se...
FEops HEARTguide LAA workflow integrated into TeraRecon software
FEops has entered into a partnership with ConcertAI’s TeraRecon for the commercialisation of FEo...
US FDA grants IDE approval for PROACTIVE-HF 2 study of Cordella pulmonary artery sensor
Endotronix has received investigational device exemption (IDE) approval from the US Food and Dru...
EACTS 2023: On-X aortic valve “remains safe and effective with low dose warfarin”
Data from the On-X aortic heart valve low INR post-market study, presented during a late-breakin...
Elixir Medical submits approval for DynamX coronary bioadaptor in Japan
Elixir Medical has announced submission to Japan’s Pharmaceutical and Medical Device Agency (PMD...
EACTS 2023: Statin treatment may benefit SAVR patients
Ongoing statin treatment may be beneficial for patients after isolated surgical aortic valve rep...
US FDA approval for AI-powered left ejection fraction detection device
Anumana has announced US Food and Drug Administration (FDA) 510(k) clearance for ECG-AI LEF, a break...
MedAlliance acquired by Cordis
MedAlliance has been acquired by Cordis for a 2022 investment of US$35 million and a 2023 upfront cl...
US FDA grants conditional IDE approval for F2 cerebral embolic protection system
EnCompass Technologies has announced that the US Food and Drug Administration (FDA) has granted cond...
Boston Scientific gains US FDA clearance for AVVIGO+ multi-modality guidance system
Boston Scientific has announced US Food Administration (FDA) clearance of the AVVIGO+ multi-modality...
Surgeons perform historic second transplant of a genetically modified pig heart into a human
Surgeons at the University of Maryland Medical Center (UMMC, Baltimore, USA) have performed the seco...
Nitrate reduces contrast-induced necropathy during coronary angiography
Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces ca...
Nick West appointed to associate CMO role at Shockwave Medical
Shockwave Medical has announced that Nick West has joined the company in the role of associate c...
David Hildick-Smith
As one of the UK’s leaders in interventional cardiology, David Hildick-Smith (University Hospitals S...
Cardiovascular News – Issue 70 – September 2023: US Edition
In this issue:
Societies weigh in on renal denervation as US Food and Drug Administration (FDA)...
Cardiovascular News – Issue 70 – September 2023: OUS Edition
In this issue:
Societies weigh in on renal denervation as US Food and Drug Administration (FDA)...
Pivotal study of ShortCut leaflet splitting device completes enrolment
Pi-Cardia has announced the successful completion of its ShortCut pivotal study enrolment.
ShortC...
ADVERTORIAL: Hypertension guidelines “change the thinking” on renal denervation
This advertorial is sponsored by Medtronic
Hypertension is a leading cause of heart attack, strok...
European survey highlights lack of uniformity in heart team implementation
A survey of cardiac surgeons and interventional cardiologists from 26 European nations has highlight...
Updates to HyperVue intravascular imaging system approved by US FDA
SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance for product enhance...
Enrolment complete in SAFE-MCS study of Early Bird bleed monitoring system
Saranas has completed enrolment in SAFE-MCS, a multicentre, single arm, open-label clinical trial ev...
Half of patients enrolled in SELUTION DeNovo coronary trial
MedAlliance has announced enrolment of over 1,660 patients in its SELUTION DeNovo coronary randomise...
Large annulus valve launched for transseptal mitral valve replacement system
HighLife SAS has announced the introduction of a new valve size in its clinical trials of a transsep...
Ten-year NOTION trial data provide important insights on long-term TAVI outcomes and valve durability
Ten-year data from the NOTION trial—the longest-running clinical trial to date to compare outcom...
Watchman FLX Pro gains US FDA approval
Boston Scientific has received US Food and Drug Administration (FDA) approval for the latest-gen...
Enrolment begins in LOVE-DEB study of Selution SLR sirolimus-eluting balloon
The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease tr...
First-in-man procedure follows US FDA breakthrough designation for NyokAssist PVAD system
The first-in-man (FIM) use of the NyokAssist (magAssist) percutaneous ventricular assist device ...
ESC 2023: Study assesses impact of using Heartflow FFRCT for diagnosing coronary artery disease
A study assessing the impact of the addition of adding coronary computed tomography angiography ...
Sirolimus-eluting Orsiro stent non-inferior to zotarolimus-eluting device in BIOFLOW-DAPT trial
One-year-data from the BIOFLOW-DAPT trial demonstrated non-inferiority and a good safety profile for...
Stroke expert J Mocco joins Protembis board
Protembis has announced the appointment of J Mocco (Icahn School of Medicine at Mount Sinai, New Yor...
Radiaction Medical secures Series C2 funding and announces board addition
Radiaction Medical has raised US$12.6 million in Series C2 funding led by US private equity fund Inn...
UK MHRA adds capacity for medical device certification
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new app...
ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events
Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI...
ESC and EACTS conclude review of left main revascularisation guidelines recommendations
A joint review of evidence into the treatment of patients at low surgical-risk with left main corona...
ESC 2023: ECLS not shown to improve survival in patients with acute MI complicated by cardiogenic shock
Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocar...
ESC 2023: ADVENT trial shows PFA is non-inferior to thermal ablation for safety and efficacy in paroxysmal AF
Results of the first randomised trial comparing pulsed field ablation (PFA) to thermal ablation ...
ESC 2023: GE Healthcare showcases latest-generation handheld ultrasound scanner and AF tool
GE Healthcare has announced the launch of two new tools for the cardiology market, coinciding wi...
ESC 2023: Hot Line trials add weight to case for intravascular imaging during PCI
Data from three randomised trials and a meta-analysis presented at the European Society of Cardi...
ESC 2023: Siemens unveils Acuson Origin imaging platform
Siemens Healthineers has unveiled the Acuson Origin, a dedicated cardiovascular ultrasound system wi...
SCAI: FDA panel vote “encouraging” for advance of renal denervation
The Society for Cardiovascular Angiography & Interventions (SCAI) has welcomed the review of sci...
FDA panel split on risk and benefit of Symplicity Spyral renal denervation system
The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel met yesterday (23 Au...
First two US patients receive Trisol tricuspid valve
The heart teams at the Piedmont Heart Institute (Atlanta, USA) and the University of Virginia He...
FDA panel votes favourably on safety and efficacy of Paradise renal denervation system
The US Food and Drug Administration (FDA) Circulatory Systems Devices Panel of the Medical Devices A...
ESC 2023: Risk of MI recurrence higher in patients who do not take daily aspirin
Myocardial infarction (MI) patients who do not take daily aspirin have an elevated likelihood of rec...
Elevate pLVAD completes early feasibility study
Enrolment has been completed in the US Food and Drug Administration (FDA)-approved early feasibility...
Advanced NanoTherapies secures investment for development of SirPlux Duo DCB
Advanced NanoTherapies—ANT—has announced the completion of a US$4million Series A extension from...
SCAI position statement “aims to pave the way for renal denervation in the management of hypertension”
The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statem...
Bryan Williams joins BHF as research leader
The British Heart Foundation (BHF) has appointed research leader and NHS consultant physician Br...
Sham-controlled trials prompt renal denervation hypertension guideline update
Latest research in the field of renal denervation has prompted its inclusion in updated guidelin...
Forxiga granted approval from China’s NMPA for treatment of symptomatic chronic heart failure
AstraZeneca’s Forxiga (dapagliflozin) has been approved in China for use in adults with symptomatic ...
First patient enrolled in global study of heart failure device trial
Heart failure start-up Acorai has announced the initiation of a global clinical trial with the e...
AI model may improve detection of atrial septal defect
An artificial intelligence (AI) model may be more efficient at detecting signatures of atrial septal...
Efforts needed to improve cardiovascular research in Africa
Research published in the journal Circulation: Cardiovascular Quality and Outcomes has highlight...
STS risk calculator uses power of big data to predict cardiac surgery risk
A new digital tool launched by the Society of Thoracic Surgeons (STS) draws together data from m...
US FDA grants de novo approval for AI-based HCM detection algorithm
Viz.ai has received a de novo approval by the US Food and Drug Administration (FDA) for its Viz ...
STAR-T trial of DrugSorb-ATR completed
CytoSorbents has announced the completion of the pivotal STAR-T (Safe and Timely Antithrombotic Remo...
Orchestra BioMed gains FDA nod to begin study of Virtue SAB sirolimus balloon
Orchestra BioMed Holdings has been granted US Food and Drug Administration (FDA) investigational dev...
First US implants mark start of DurAVR THV early feasibility study
Anteris Technologies has reported that its DurAVR biomimetic, single-piece transcatheter aortic ...
Ilika and Cirtec Medical partner on manufacture and commercialisation of Stereax solid-state batteries
Ilika and Cirtec Medical have announced that they have signed a 10-year manufacturing licence to pro...
VenusP-Valve gains FDA authorisation for transpacific clinical study
Venus Medtech has announced US Food and Drug Administration (FDA) Investigational Device Exemption (...
Canon Medical launches Alphenix / Evolve Edition angiography system in Europe
Canon Medical has introduced its Alphenix / Evolve Edition angiography system for commercial sale in...
“Not just inventing the next stent”: The future of medtech relies on patient empowerment
Ian Meredith is a well-known figure within the field of interventional cardiology, not only for ...
Cardiovascular News’ top 10 stories of July 2023
Hitting the headlines in July were new European guidelines on the treatment of arterial hyperten...
CMS creates new MS-DRG codes and payments for coronary IVL
Shockwave Medical has announced that as part of the Fiscal Year 2024 Medicare Hospital Inpatient Pro...
WHO adds cardiovascular polypill to essential medicines list
The World Health Organization (WHO) has included a cardiovascular polypill—an all-in-one pill contai...
TaurusTrio TAVI device gets first implants in aortic regurgitation clinical study
Peijia Medical has announced that the first Chinese patient has been enrolled in the clinical trial ...
Laplace Interventional secures funding for clinical testing of transcatheter tricuspid valve technology
Laplace Interventional, a medical device company developing a transcatheter tricuspid valve tech...
First patients treated in Indian clinical trial of Tria surgical mitral valve
Foldax has announced that the first 30 patients have been treated outside of the USA in the Indi...
Transfemoral TAVI device gains US FDA breakthrough status for aortic regurgitation
Genesis MedTech has announced that its J-Valve transfemoral (TF) system has been granted breakthroug...
Study confirms AI detection of HFpEF using a single echocardiogram view
Applying artificial intelligence (AI) to a single apical four chamber (A4C) view echocardiogram ...
Results from studies of HeartFlow coronary technologies shared at SCCT conference
Respective results from the REVEALPLAQUE, DECODE, and SMART-CT were presented at the Society of ...
First valve-in-valve procedure performed with DurAVR transcatheter valve
Anteris Technologies has announced that the DurAVR transcatheter heart valve (THV) was used for ...
CardioPrecision moves into US market
CardioPrecision, a developer of less invasive treatment solutions for structural heart disease, has ...
EACTS puts innovation to the fore
Innovation is a part of the DNA of cardiothoracic surgery, Friedhelm Beyersdorf (Heart Center Fr...
Michael Jaff joins board of directors at HeartBeam
HeartBeam, developer of a 3D-vector electrocardiogram (VECG) platform, has announced the appoint...
Clinical trial to compare PCI and CABG in women and minorities
Researchers will carry out the first clinical trial focusing on women and minority populations to de...
Extreme temperatures and particulate pollution may increase MI mortality risk
The combination of soaring heat and fine particulate pollution may double the risk of myocardial inf...
Global Cardiovascular Awards to recognise excellence and innovation in cardiovascular care
Entries are now open for the inaugural edition of the Global Cardiovascular Awards, a recognition sc...
Onecrea Medical announces successful first-in-human implants of Crea aortic valve
Onecrea Medical has announced the success of the first-in-human implants of its transcatheter aortic...
PECA Labs appoints new board members
PECA Labs has added Jeffrey P Carpenter, Jeffrey O’Donnell Sr and Samuel E Navarro to its board of d...
SCAI welcomes FDA decision to remove red flag for use of paclitaxel-coated devices in PAD
The president of the Society for Cardiovascular Angiography & Interventions (SCAI), George D...
Ian Meredith joins board of directors at Avertix Medical
Avertix Medical—formerly known as Angel Medical Systems—has announced that Ian Meredith has agre...
TIMELY study will assess impact of AI platform on health of MI patients with coronary disease undergoing cardiac rehabilitation
The TIMELY consortium announced today the enrolment of the first patient in the randomised controlle...
ESH guidelines represent a “significant milestone” for hypertension management
ReCor Medical and its parent company Otsuka Medical Devices have welcomed the release of updated...
INFINITY-SWEDEHEART trial of DynamX bioadaptor system completes enrolment
Elixir Medical has announced enrolment completion in INFINITY-SWEDEHEART, a prospective, multice...
Randomised trial “highly needed” to shed light on effectiveness of TAVI in bicuspid aortic stenosis patients
A dedicated, prospective randomised controlled trial (RCT) investigating the safety, efficacy and li...
Patient advocacy group says ESH guideline change will improve access to renal denervation
Citizens of Europe at risk for heart attacks, stroke and chronic kidney disease due to uncontrolled ...
HOST-IDEA sub-analysis uncovers differences in ultrathin stent platforms
Results of a stent-level analysis from the HOST-IDEA study, which compared two ultrathin strut d...
Gut bacteria linked to coronary atherosclerotic plaques
In a major Swedish study, researchers have discovered a link between the levels of certain bacte...
Timeline: Key milestones in the paclitaxel story
The release of a letter from the US Food and Drug Administration (FDA) concerning the use of paclita...
Approval granted to commence study of renal pelvis denervation system
Verve Medical has received approval from the US Food and Drug Administration (FDA) to initiate its N...
First US patients implanted with FIRE1 remote heart failure monitoring system
FIRE1 has announced that the first US patients have been successfully implanted with its FIRE1 syste...
Long-awaited US FDA update finds data do not support excess mortality risk for paclitaxel-coated devices
In a letter to healthcare providers dated 11 July 2023, the US Food and Drug Administration (FDA...
First patient enrolled in MOJAVE study of DSR 2.0
Sequana Medical NV has announced that the first patient has been enrolled in the MOJAVE study, a ran...
Alvimedica launches Kaplan curves radial portfolio for diagnostic procedures
Alvimedica has announced the launch of the Alvision Kaplan curves radial portfolio for diagnostic pr...
Streamlined TAVI pathway paves the way for same-day discharge “record”
Physicians at the James Cook University Hospital (Middlesbrough, UK) have performed ten transcat...
Researchers develop flexible bioresorbable monitor for cardiac patients
Researchers have developed a soft, fully bioresorbable, transparent microelectrode array (MEA) for m...
“World’s first” dual chamber leadless pacemaker system granted US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir dual cham...
Key messages from EBC MAIN at three years
EBC MAIN investigator David Hildick-Smith (Brighton, UK) delivers key messages from the trial’s ...
Medtronic heralds ESH guidelines as a “turning point” for renal denervation
In the wake of the release of update guidelines from the European Hypertension Society (ESH) guideli...
Combination of chronic kidney disease and diabetes associated with a higher rate of death or MI among women undergoing PCI
The combined presence of chronic kidney disease and diabetes among women undergoing percutaneous cor...
Minimum level of oxygen required during cardiopulmonary bypass “may be lower than previously thought”
Researchers have found that the minimum level of oxygen delivery during cardiopulmonary bypass may b...
Translumina acquires Blue Medical Devices
Translumina has announced the acquisition of Blue Medical Devices, a Wellinq group company, base...
ALL-RISE study of CathWorks FFRangio system enrols first patient
CathWorks has announced that the first patient has been enrolled in the Advancing cath lab resul...
Depressed ICD patients “more likely to stop medications”
Patients who feel low when having a cardiac device implanted are more likely to stop taking thei...
New arterial hypertension guidelines update recommendations on the use of renal denervation
New and expanded guidelines from the European Society of Hypertension (ESH) concerning the managemen...
ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation
Anumana has received breakthrough device designation from the US Food and Drug Administration (FDA) ...
Vygon to manufacture vascular outflow tract for Aeson artificial heart
Vygon, a specialist in the design, manufacturing and marketing of medical devices, has signed an exc...
iTFlow blood flow analysis software gains US FDA approval
The US Food and Drug Administration (FDA) has approved the use of iTFlow in blood flow analysis.
...
CorWave closes series C funding round
CorWave has raised €61 million to fund its first industrial deployment and entry into clinical trial...
egnite and JenaValve partner to assess prevalence of aortic regurgitation in USA
egnite and JenaValve Technology have announced a strategic partnership aimed to offer insight on the...
Anxiety affects high proportion of patients with an ICD
Nearly one-third of patients with an implanted device to prevent sudden death have anxiety in th...
CHOP physicians conduct first-in-human implant of MASA polymeric pulmonary valve
PECA Labs has announced the successful first-in-human implant of the MASA valve, a polymeric valved ...
Pacing wire for TAVI and balloon aortic valvuloplasty procedures gains US FDA clearance
Teleflex has received US Food and Drug Administration (FDA) clearance for the Wattson temporary paci...
STEMI patients “lose years of life” due to care delays during COVID-19 lockdowns
Patients with ST-elevation myocardial infarction (STEMI) occurring during the first COVID-19 loc...
EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis
Results of the first study of a first-generation drug-coated balloon (DCB) with a biolimus coati...
US FDA approval for AI TAVI planning software
Dasi Simulations has announced it has received US Food and Drug Administration (FDA) clearance for i...
ESC appoints Jean-François Riffaud as CEO
The European Society of Cardiology (ESC) has announced the appointment of Jean-François Riffaud ...
Translumina extends European reach with Lamed acquisition
Translumina has announced the acquisition of Munich-based Lamed GmbH, which the company says mov...
US FDA seeks to “modernise” clinical trials with new draft guidance
The US Food and Drug Administration (FDA) has released draft guidance with updated recommendatio...
Research highlights “strikingly low” use of public defibrillators in cardiac arrest
Defibrillators are being used in just one in 10 cardiac arrests where they are available, according ...
Lars Søndergaard joins Abbott’s structural heart business
Lars Søndergaard has left his role as professor of cardiology at Rigshospitalet, Copenhagen Universi...
Conformal Medical completes series D financing round
Conformal Medical has announced the successful completion of its series D funding round, raising...
First TAVI procedures performed using F2 cerebral embolic filter
EnCompass Technologies has announced its novel F2 cerebral embolic filter was used successfully in t...
Amazon executive joins Medtronic to spearhead development in robotics and implantables
Medtronic has announced that Ken Washington has been appointed chief technology and innovation offic...
First-in-man implant of “modular” TAVI device performed in Israel
Valve Medical, a wholly owned subsidiary of Medinol Ltd, has announced the first-in-human (FIH) impl...
ADVERTORIAL: Keeping stroke at bay for patients undergoing TAVI
This advertorial is sponsored by Boston Scientific
Stroke—particularly disabling stroke—is among ...
MONITOR-HF trial results show improvement in quality of life scores for heart failure patients with CardioMEMS system
New data presented from an investigator-sponsored European trial found managing indicated heart fail...
Proprietary antioxidant complex shown to safeguard DNA from radiation exposure during aortic procedures
Cora Therapeutics has announced the presentation of the results of a clinical trial at the Canad...
SCAI 2023: Similar revascularisation rates seen with ticagrelor monotherapy and DAPT in TWILIGHT trial
Ticagrelor monotherapy after three months of ticagrelor plus aspirin was associated with similar...
HRS 2023: BIO-LIBRA study offers insights into device treatment of non-ischaemic cardiomyopathy
Preliminary results from the BIO-LIBRA study, assessing the outcomes of device-treated ventricul...
HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat heart failure”
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchroni...
Ruggero De Paulis
Inventor of the Valsalva aortic graft Ruggero De Paulis (European Hospital Unicamillus University, R...
Cardiovascular News – Issue 69 – May 2023: US Edition
In this issue:
A new era for intracoronary imaging
Top trials from ACC 2023
Profile: Rugg...
TVT registry analysis finds close to 90% success in mitral TEER procedures
A large registry study of patients undergoing transcatheter edge-to-edge repair (TEER) for degen...
HRS 2023: Researchers hope to use AI to “revolutionise” prediction of sudden cardiac death
A novel artificial intelligence (AI) model correctly identified patients at near-term risk of sustai...
EuroPCR 2023: Global SYMPLICITY registry offers renal denervation insights out to three years
Analysis of the Global SYMPLICITY registry DEFINE (GSR DEFINE), presented at EuroPCR 2023 (16–19...
Finding the roots of the disease before treating it: Modelling NSTEMI
Paolo Contessotto (National University of Ireland Galway, Galway, Ireland) outlines his research dev...
SCAI 2023: No increased risk of hand dysfunction from distal compared to proximal radial artery access for cardiac procedures
A randomised controlled trial comparing the safety of distal versus proximal radial artery access fo...
SCAI 2023: Mechanical thrombectomy improves symptoms and quality of life in pulmonary embolism patients at six months
Six-month outcomes from FLASH registry have shown that patients with pulmonary embolism who were tre...
SCAI 2023: Two-year results “demonstrate strong clinical and haemodynamic outcomes” of Harmony transcatheter valve
Medtronic has announced two-year results for its Harmony transcatheter pulmonary valve (TPV) system,...
EuroPCR 2023: One-year BIOMAG-I results demonstrate safety and efficacy of resorbable scaffold platform
Results of the first-in-human study BIOMAG-I study, assessing Biotronik’s latest-generation Drea...
SCAI 2023: NACMI registry finds increased incidence of clotting among STEMI patients with COVID-19
Analysis from The North American COVID-19 STEMI (NACMI) registry, presented as late-breaking cli...
SCAI 2023: George Dangas begins term as SCAI president
The Society for Cardiovascular Angiography & Interventions (SCAI) has named George Dangas (I...
EuroPCR 2023: BIOADAPTOR trial shows non-inferiority of DynamX scaffold to DES for TLF at 12 months
Elixir Medical has announced that the BIOADAPTOR RCT trial of the company’s DynamX coronary drug...
EuroPCR 2023: Benchmark Registry data demonstrate improved TAVI efficiency
New data from the Benchmark Registry, a study of a streamlined transcatheter aortic valve implantati...
EuroPCR 2023: Carbon dioxide flushing prior to TAVI may offer protection against brain injury
A process of flushing prosthetic valves using carbon dioxide (CO2) prior to transcatheter aortic...
AATS 2023: COMMENCE aortic trial data shared through seven years
Edwards Lifesciences has announced new data from the COMMENCE aortic trial, demonstrating low ra...
EuroPCR 2023: Chimney stenting and BASILICA both seen to be effective in preventing TAVI-related coronary obstruction
A real-world comparison of two techniques aimed at reducing the risk of coronary obstruction aft...
EuroPCR 2023: Three-year EBC MAIN results demonstrate need for pragmatism in left main bifurcation stent strategy
Operators performing percutaneous coronary intervention (PCI) in bifurcation left main stem sten...
EuroPCR 2023: Imaging technology reduces contrast use during PCI
The use of an image-guidance system that overlays angiographic images on live fluoroscopic image...
Cardiovascular News – Issue 69 – May 2023: OUS Edition
In this issue:
A new era for intracoronary imaging
Top trials from ACC 2023
Profile: Rugg...
EuroPCR 2023: Robocath launches new robotic PCI platform
Robocath has announced the launch of its latest robotic platform—the R-One+.
The company is showc...
Shockwave Medical’s C2+ coronary IVL catheter launched in select markets
Shockwave Medical has announced the full commercial availability of the Shockwave C2+ coronary intra...
Foldax acquires proprietary polymer patent family
Foldax has announced that it has executed an agreement with Australia’s national science agency,...
SavvyWire to be assessed in COMPLETE TAVR substudy
OpSens has announced the inclusion of SavvyWire in the COMPLETE TAVR clinical study to investigate t...
Turning extra pulses into pluses
This educational supplement, sponsored by Shockwave Medical, gains fresh perspective on the manageme...
More shocks for rocks
How has the new Shockwave C2+ catheter changed the treatment of calcified coronary lesions at He...
Managing eccentric and nodular calcium with IVL
Calcified nodules are frequently identified among coronary artery lesions and are associated wit...
The r(evolution) of calcium in Bristol
Tom Johnson (University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK) outlin...
ADVERTORIAL: Ongoing studies add to evolving understanding of TAVI valve durability
This advertorial is sponsored by Medtronic
New data offer greater perspective on the long-ter...
ADVERTORIAL: Ready for the primetime? The future role of drug-coated balloons in PCI
This advertorial is sponsored by B Braun Melsungen AG
“The evolution of PCI has always been a co...
US FDA expands indication for Farxiga
AstraZeneca’s Farxiga (dapagliflozin) has been approved in the USA to reduce the risk of cardiovascu...
First patient treated in head to head trial of TAVI embolic protection devices
Emboline has announced that the first patient has been treated in the Protect the Head to Head inves...
Handheld ECG device scoops CX 2023 Innovation Showcase prize
Judges of the CX 2023 Dragon’s Den-style contest — the finale of the Day 3 CX Innovation Showcas...
Study highlights disparity in TAVI outcomes based on availability
Research has highlighted significant regional variations in the availability of transcatheter ao...
Ultromics’ AI platform for detecting cardiac amyloidosis gains FDA breakthrough status
Ultromics has been granted US Food and Drug Administration (FDA) breakthrough device status for its ...
Carillon mitral contour system gains EU MDR certification
Cardiac Dimensions has announced that its Carillon mitral contour system, for the treatment of f...
CAAS Qardia gains Japanese certification
Pie Medical Imaging has received NINSHO Medical Device Certification for CAAS Qardia, its echocardio...
First US implant of Lux-Valve Plus transcatheter tricuspid valve performed in Detroit
The first transcatheter tricuspid valve replacement procedure in the USA using the LuX-Valve Plu...
Shockwave Medical completes Neovasc acquisition
Shockwave Medical has announced the completion of its previously announced acquisition of Neovas...
OpSens completes European enrolment in SAFE-TAVI study
OpSens has announced the successful completion of enrolment in the SAFE–TAVI clinical study, studyin...
Cardiovascular News’ top 10 stories of March 2023
The news agenda in March was dominated by late-breaking data from the American College of Cardiology...
Research project to determine how stretching and blood flow impact engineered heart valves
New research will investigate how stretching and blood flow can inhibit or encourage cardiovascu...
Medtronic launches technology aimed at simplifying MRI screening for patients with implanted cardiac devices
Medtronic has announced the launch of MRI Care Pathway, a new system designed to streamline the proc...
PROACTIVE-HF pivotal trial completes enrolment
Endotronix has announced its PROACTIVE-HF pivotal study has successfully completed enrolment.
...
Smart glasses guide remote support for pioneering TAVI procedure
The UK’s first remotely-supported transcatheter aortic valve implantation (TAVI) using smart glasses...
Enrolment target met in ECLIPSE coronary atherectomy trial
Cardiovascular Systems has announced the complete enrolment of its 2,000-patient ECLIPSE coronar...
Experts update consensus on left atrial appendage closure
The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Socie...
Abbott’s Epic Max stented tissue aortic valve gains US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's E...
Azeem Latib joins Supira Medical as medical director
Supira Medical has announced the appointment of Azeem Latib (Montefiore Health Systems, New York...
ADVERTORIAL: “No stroke is innocent”: Why stroke matters for TAVI patients
This advertorial is sponsored by Boston Scientific
Today there are more than 75,000 transcatheter...
PADN-5 study results “exciting” for pulmonary artery denervation in heart failure and CpcPH patients
Results from the PADN-5 study, investigating the efficacy and safety of pulmonary artery denerva...
Enrolment reaches midway point in trial of Early Bird bleed monitoring system
Saranas has announced that it has reached the midpoint for enrolment in SAFE-MCS, a multicentre, sin...
Thousandth patient enrolled in SELUTION DeNovo coronary study
MedAlliance has announced enrolment of over 1,000 patients in its SELUTION DeNovo coronary randomise...
Immediate revascularisation non-inferior to staged procedure in acute coronary syndrome and multivessel disease
Immediate, complete revascularisation with percutaneous coronary intervention (PCI) in patients ...
Robotic electrophysiology programme opens in south eastern USA
Stereotaxis has announced the opening of a new robotic electrophysiology programme at Broward He...
BIOMAG-I study demonstrates low rate of in-scaffold late lumen loss at six months
Angiographic and clinical data from the BIOMAG-I clinical study, presented at the 2023 Cardiovas...
US FDA approval for Essenz heart-lung machine
LivaNova has announced the receipt of US Food and Drug Administration (FDA) 510(k) clearance for its...
ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI
Assessing myocardial viability does not aid the selection of patients who will benefit—or not—fr...
Cardiovascular News’ top 10 stories of February 2023
February’s trending topics included a look at the past, present and future of transcatheter aortic v...
New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients
Edwards Lifesciences has highlighted new data examining mortality rates and cardiac damage of ea...
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for ...
ACC 2023: Pulsed AF trial yields “promising” safety and efficacy results for PFA system
Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation (PFA) treatment in p...
ACC 2023: Equivalent recovery times shown between minimally invasive and conventional surgery for mitral valve repair
The largest randomised controlled trial to date to compare minimally invasive and conventional c...
Neovasc shareholders approve acquisition by Shockwave Medical
Neovasc has announced that its shareholders have approved the previously-announced acquisition o...
ACC 2023: Intravascular imaging bests angiography guidance in trial of PCI in complex lesions
Use of intravascular imaging guidance for percutaneous coronary intervention (PCI) in patients with ...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with ...
ACC 2023: MitraClip meets endpoints at five years in COAPT trial
Final, five-year clinical outcomes from the COAPT trial, evaluating transcatheter mitral valve r...
ACC 2023: Benefit of TAVI “consistent” over first three years in low risk patients
Three-year results from the Evolut Low Risk trial have shown “durable” benefits of transcatheter...
ACC 2023: Quality of life improvements drive benefit for transcatheter therapy in TRILUMINATE pivotal trial
Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, presented during the 2023...
Preclinical model could aid future research of NSTEMI therapies
Researchers have detailed a new preclinical model for non-ST elevation myocardial infarction (NSTEMI...
HyperVue intracoronary imaging system gains US FDA approval
SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance of its flagship int...
CRT 2023: Abbott shares new data on Navitor TAVI and Amplatzer Amulet LAAO systems
Results from the PORTICO NG study of Abbott’s Navitor transcatheter aortic valve implantation (TAVI)...
Five-year durability analysis of CoreValve and Evolut platforms “underscores long-term promise of TAVI”
Five-year bioprosthetic valve dysfunction data for Medtronic’s CoreValve and later-generation Ev...
Results of cell therapy trial in patients with heart failure due to low EF published in JACC
Results of a trial involving cell therapy in patients with chronic heart failure due to low ejec...
CONFORMAL EFS study results presented at CRT 2023
Results from the CONFORMAL early feasibility study (EFS), evaluating the use of angiography comp...
Risk model adds to prediction tools for surgical risk in adult congenital heart disease patients
A model designed to predict surgical risk in the setting of adult congenital heart disease (ACHD) im...
Medtronic welcomes ESC and EAPCI renal denervation consensus statement
Medtronic has welcomed the publication of the consensus statement on renal denervation issued by the...
First patient treated in A PRIORI pilot trial of Aortix circulatory support device
Procyrion has announced the successful treatment of the first patients in the A PRIORI—Aortix therap...
Medtronic relaunches Harmony transcatheter pulmonary valve
Medtronic has announced the relaunch of its Harmony transcatheter pulmonary valve (TPV) system, a mi...
Barostim misses primary endpoint in BEAT-HF postmarket trial
CVRx has announced the preliminary topline results of the BeAT-HF—Baroreflex activation therapy for ...
US FDA clears tool to rapidly analyse RV/LV ratio
RapidAI announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid R...
Renal denervation “can reach new shores”
The publication of a consensus statement from the European Society of Cardiology (ESC) Council o...
Teleflex grows catheter portfolio following US FDA approval
Teleflex Incorporated has today announced key milestones in the release of two new catheters, includ...
Xeltis secures funding to progress clinical trials
Xeltis has raised €32 million in a Series D2 equity fundraise, backed by a syndicate of current and ...
ACC, AHA and SCAI lay roadmap for interventional cardiology training
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Society for C...
ESC and EAPCI publish renal denervation consensus statement
Renal denervation represents another treatment option in patients with uncontrolled resistant hypert...
COPS trial shows feasibility of using a cutting balloon at high pressure to modify calcium prior to PCI
Attendees of the 2023 Joint Interventional Meeting (JIM, 9–11 February, Milan, Italy) heard results ...
OPN NC “super-high-pressure” coronary balloon launches in USA
SIS Medical AG has announced the launch of its OPN NC percutaneous transluminal coronary angioplasty...
GE HealthCare to acquire AI ultrasound developer Caption Health
GE HealthCare has signed an agreement to acquire Caption Health, a developer of artificial intel...
ADVERTORIAL: DCB therapy offers a glimpse of interventional cardiology’s past and future
This advertorial is sponsored by Cardionovum
“Everything started with balloon inflations in t...
Home-based therapy can help to reduce anxiety and depression in cardiovascular patients
A randomised study led by Greater Manchester Mental Health NHS Foundation Trust (GMMH) and the U...
Cardiovascular News 68 – February 2023: US Edition
In this issue:
Medicare study reopens guideline debate around surgery and PCI in patients with ...
Cardiovascular News 68 – February 2023: OUS Edition
In this issue:
Medicare study reopens guideline debate around surgery and PCI in patients with ...
ADVERTORIAL: A step forward in scoring balloon catheter design
This advertorial is sponsored by iVascular
A new coronary scoring balloon dilatation catheter...
Automated alert tool “associated with a small decrease in contrast use” during PCI
Performance improvement company Biome Analytics has announced the publication of a study in Circulat...
TruLeaf Medical to trial “two-stage” TMVR platform
TruLeaf Medical is to conduct a first-in-human clinical trial of a “two-stage” transcatheter mit...
PCI can be performed as safely without on-site access to surgery, says SCAI
Percutaneous coronary intervention (PCI) without on-site surgical support is as safe as PCI at centr...
Cardiovascular-aortic community comes together at CX 2023
From cutting-edge aortic interventions to consensus on revascularisation strategies in the periphera...
ADVERTORIAL: A wealth of data underscore treatment choices for coronary DCBs
This advertorial is sponsored by B. Braun Melsungen AG
The modern field of percutaneous coron...
First patient treated in LeAAPS trial of left atrial appendage occlusion in cardiac surgery patients
AtriCure has announced that the first patient was treated in the LeAAPS clinical trial, a prospectiv...
Slow progress made on gender balance in cardiovascular trial leadership
Little progress has been made over the last decade in improving gender balance in leadership positio...
Nieves Gonzalo
Interventional cardiology is a rapidly evolving field, offering the opportunity to learn procedures ...
Medicare study reopens guideline debate around surgery and PCI in patients with multivessel coronary artery disease
An analysis of data from more than 100,000 patients with multivessel coronary artery disease und...
First US patient enrolled into study of Selution SLR coronary drug-eluting balloon
The first US patient has been enrolled at Medstar Washington Hospital Center (Washington DC, USA) in...
STS 2023: Risk assessment tool “sets a high bar” when considering alternatives to surgery in mitral valve repair
A new risk assessment tool has been produced to provide a comprehensive method for assessing ope...
Enrolment milestone reached in trial of angiography-based vessel fractional flow reserve in coronary revascularisation
Pie Medical Imaging has announced the enrolment of the 500th patient in the FAST III clinical trial,...
Trial of super saturated oxygen therapy after PCI begins enrolment
Zoll has announced that the first patient has been enrolled in the REAL SSO2 post-market observation...
Registry data point to a declining rate of complications among primary MR patients
The largest dedicated registry on mitral transcatheter edge-to-edge repair (M-TEER) in primary m...
Shockwave agrees to acquire Neovasc
Shockwave Medical has entered into a definitive agreement to acquire Neovasc Inc, developer of t...
US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients
The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) transcatheter aortic val...
Effects of short DAPT “consistent regardless of high bleeding risk and complex PCI”
Research evaluating the effects of high bleeding risk (HBR) and complex percutaneous coronary interv...
Pie Medical Imaging announces launch of CAAS Qardia 2.0 echocardiography software platform
Pie Medical Imaging has launched a new version of its echocardiography software platform—CAAS Qardia...
NICE lowers threshold for statins to prevent cardiovascular events
The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance recom...
HVR Cardio closes €10.7 million series B funding round
HVR Cardio has closed on a €10.7 million series B round of financing. The Series B Round was led...
Depression increases likelihood of non-adherence to medical therapy post-PCI
Patients with depression were 10–20% less likely to adhere to guideline-directed medical therapy aft...
Multidisciplinary teams at the heart of new guidelines on aortic disease management
Closer ties between cardiologists, cardiac surgeons and vascular surgeons will be a hallmark of the ...
MedAlliance’s Selution SLR receives coronary de novo IDE approval
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional US Food and Dr...
Preclinical study outlines key features of foam-based LAA closure device
A preclinical study demonstrating key features of the foam-based left atrial appendage closure d...
Cardiac Dimensions closes funding round to support US EMPOWER pivotal study
Cardiac Dimensions has closed a US$35 million Series D financing round. The financing was co-led...
Funding secured to advance development of Pulse IVL system
AVS has announced that it raised US$20 million in Series B financing, which the company says will ac...
Cardiovascular News’ top stories of 2022
Which stories, features and interviews captured the attention of the cardiovascular community across...
SCAI announces recipients of early career grant scheme
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the four recipie...
No sex difference seen in outcomes for transcatheter tricuspid valve intervention
Transcatheter tricuspid valve intervention is associated with similar outcomes in both women and...
ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation system
ReCor Medical and its parent company Otsuka Medical Devices have announced the appointment of La...
Enrolment begins in trial to assess new therapy in patients deemed unsuitable for anticoagulants
Anthos Therapeutics has announced that it has enrolled the first patient in LILAC-TIMI 76, a pha...
Johnson & Johnson completes Abiomed acquisition
Johnson & Johnson has today announced it has completed its acquisition of Abiomed. Abiomed is no...
Machine learning enables “clinically important” characterisation of coronary artery disease
Using machine learning and clinical data from electronic health records, researchers have constructe...
Stem cell plasters “could revolutionise treatment of congenital heart disease”
Researchers have developed ‘stem cell plasters’ which it is hoped will revolutionise the way sur...
Enrolment begins in Impella ECP pivotal trial after US FDA green light
The first two patients have been enrolled in the Impella ECP pivotal trial, after the US Food an...
STAR-T trial of antithrombotic removal system during cardiac surgery to continue
CytoSorbents Corporation has received the recommendation from the independent Data and Safety Mo...
First US procedure performed using ShortCut leaflet splitting device
Pi-Cardia has announced that the first patient in the USA has been successfully treated with ShortCu...
Cardiology societies urge rethink of randomised controlled trial design
The current model for randomised clinical trials must be redesigned for the modern age, according to...
Pilot study of wire pacing sleeve yields positive results in TAVI and PCI procedures
A first-in-human trial using a purpose-built device to provide direct wire pacing without the need f...
Corindus rebrands to Siemens Healthineers Endovascular Robotics
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedi...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the tran...
UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...
TRICares secures financing to fund development of Topaz tricuspid valve replacement system
TRiCares has announce the second closing and completion of its Series C financing round, successfull...
First patient randomised in RESPONDER-HF trial of Corvia atrial shunt
Corvia Medical has announced that the first patient has been randomised in RESPONDER-HF, a globa...
ESC warns of cardiac device shortage due to implementation of MDR regulations in Europe
The European Society of Cardiology (ESC) has urged European Union (EU) health ministers to act to pr...
Postmarket data point to lower rates of PVL with Acurate neo2 TAVI valve
The addition of an annular sealing skirt, among other design changes in the Acurate neo2 transca...
TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation
One-year results from the TRISCEND study, investigating the Evoque (Edwards Lifesciences) tricus...
ADVERTORIAL: TAVI valve durability and reliability: How patient lifetime management is evolving
This advertorial is sponsored by Medtronic
Durability, reliability, accuracy. These are just ...
DurAVR heart valve system gets green light from US FDA for early feasibility study
Anteris Technologies has announced that the US Food and Drug Administration (FDA) has conditionally ...
First implant of MonarQ tricuspid valve replacement system performed in Copenhagen
inQB8 Medical Technologies, in partnership with Peijia Medical, has announced first successful i...
Nyra Medical secures investment for transcatheter mitral valve repair technology
Nyra Medical has announced the closing of a US$20 million Series A financing.
The round was c...
First-in-human procedure performed using Impella RP Flex
The first implant procedure using the Impella RP Flex (Abiomed) percutaneous pump, following its rec...
Late-breaking Xlimit randomised trial data shared at CSC 2022 congress
Data presented at an innovation session at the 2022 Structural and Coronary Intervention Course (CS...
Timothy D Henry
A pioneer of one of the first regional ST-segment elevation myocardial infarction (STEMI) systems in...
Carmat resumes commercial implants of Aeson artificial heart
Carmat has announced the resumption of commercial implants of its Aeson total artificial heart.
C...
CroíValve reports successful first in human implants of its Duo tricuspid coaptation valve system
CroíValve has announced the successful first in human implants of its Duo tricuspid coaptation v...
Cardiovascular News 67 – November 2022: OUS Edition
In this issue:
Latest evidence from key renal denervation trials
REVIVED-BCIS 2: PCI fails t...
Cardiovascular News 67 – November 2022: US Edition
In this issue:
Latest evidence from key renal denervation trials
REVIVED-BCIS 2: PCI fails t...
Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND
Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in rates of all-cause mo...
AI system to aid decision making for aortic aneurysm treatment
Viz.ai has announced a partnership with Illuminate, a developer of proprietary natural language proc...
Use of clinical support platform “reduces risk of kidney injury” from PCI
Patients at high risk for acute kidney injury (AKI), the most common complication of percutaneous co...
RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief
WL Gore & Associates has announced that it is initiating the RELIEF clinical study—an invest...
Neovasc Reducer assigned outpatient reimbursement code from CMS
Neovasc has announced that the Centers for Medicare and Medicaid Services (CMS) has assigned the Neo...
New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines
The American College of Cardiology (ACC) and American Heart Association (AHA) have jointly published...
Johnson & Johnson reaches agreement to acquire Abiomed
Johnson & Johnson is to acquire Abiomed, it was announced today, after the two organisations ent...
Impella RP Flex with SmartAssist receives US FDA approval to treat right heart failure
Abiomed has announced that Impella RP Flex with SmartAssist has received US Food and Drug Administra...
Carmat gains approval to resume clinical study of total artificial heart
Carmat, developer of the Aeson total artificial heart, has announced that it has been granted th...
US FDA accepts post-approval study reports for Impella
Abiomed has announced the US Food and Drug Administration (FDA) has accepted and closed the post...
First patients treated in SAFE-TAVI clinical study
OpSens Medical has announced the successful completion of the first cases in a clinical study—SAFE-T...
Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received US Food and Drug Administr...
Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin
In patients undergoing coronary artery bypass graft (CABG) surgery, the addition of ticagrelor t...
LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke
Researchers are to investigate the safety and efficacy of performing left atrial appendage occlu...
AccurKardia and Mawi link up to add automated ECG analytics for the new Mawi Watch
AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocard...
HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products
HeartFlow has received US Food and Drug Administration (FDA) 510(k) clearance on two new, AI-pow...
MedAlliance to be acquired by Cordis
MedAlliance is to be acquired by Cordis, it was announced today, after the two companies reached agr...
Rates of stroke and embolism lower with apixaban compared to rivaroxaban
In a large, population-based study of patients with atrial fibrillation (AF) and valvular heart dise...
Abiomed gains FDA approval for Impella low profile sheath
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed to market a ne...
Swedish registry data point to survival benefit for younger patients undergoing CABG
An analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) has s...
Analysis shows survival benefit in high-risk PCI supported by Impella
An analysis of more than 2,000 patients from a large US real-world database finds that patients ...
Swedish and Dutch organisations agree to research collaboration
The Uppsala Clinical Research Center (UCR) and the European Cardiovascular Research Institute (E...
Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award
The developers of a cannula for minimally-invasive central aortic perfusion—MIC-Cannula—received...
CathWorks gains Japanese regulatory approval for FFRangio system
CathWorks has announced approval of the fourth generation CathWorks FFRangio system by the Japan...
EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy
A global research initiative will compare coronary artery bypass graft surgery (CABG) and percut...
EACTS 2022: “Wake up call” for trialists over gender balance
Clinical trials in cardiothoracic surgery must ensure that sufficient numbers of women are enrol...
Latest data underscore optimism for future of renal denervation
Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyterian Hospital, New York...
Long-term P2Y12 monotherapy after PCI “may be a promising strategy”
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor monotherapy was asso...
Enrolment completed in trial comparing PCI in diabetic patients
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing safety and efficacy of...
Puzzle Medical wins 2022 TCT Shark Tank innovation competition
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation competition at the 2...
Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures
The use of rivaroxaban for seven days after a transradial coronary procedure reduced the rate of...
Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients
Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To...
First US TAVI procedure performed using SavvyWire guidewire
OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristown, USA) has perform...
Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022
Biotronik has announced the presentation of new full-cohort two-year BIOSOLVE-IV data. In a post...
FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI
Medtronic has received Food and Drug Administration (FDA) approval for the treatment of non-left mai...
Clinical trial of TAVI in severe aortic regurgitation completes enrolment
JenaValve Technology has announced the successful completion of patient enrolment in the ALIGN-AR Pi...
TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation
Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...
TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures
Results from a multicentre randomised trial comparing ultrasound with fluoroscopic guidance vers...
Medtronic expands US rollout of Evolut FX TAVI system
Medtronic has announced the expanded US market release of its newest-generation, self-expanding tran...
Shockwave initiates all female coronary IVL registry study
Shockwave Medical has initiated a prospective coronary intervention study consisting of all female p...
Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels
Advanced NanoTherapies has been granted US Food and Drug Administration (FDA) breakthrough devic...
TCT 2022: Amulet occluder keeps pace with Watchman at three years
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...
TCT 2022 hears “important data” from renal denervation trials
Findings from the RADIANCE II randomised pivotal trial, presented at the 2022 Transcatheter Card...
TCT 2022: Valentin Fuster receives career achievement award
The major contribution of Valentin Fuster (Mount Sinai Health System, New York, USA) to the fiel...
TCT 2022: Pascal non-inferior to MitraClip in head-to-head trial in degenerative MR patients
The first randomised trial to compare two transcatheter edge-to-edge repair (TEER) devices —CLAS...
TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR
Among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) the use of...
US FDA grants 510(k) clearance for SavvyWire TAVI guidewire
OpSens has received 510(k) regulatory clearance from the US Food & Drug Administration (FDA) for...
Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser
The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Boston, USA) opened wi...
Abiomed given green light for RECOVER IV randomised trial
Abiomed has announced two approvals from the US Food and Drug Administration (FDA) related to clinic...
Cardiac Implants announces successful adjustment procedure using its Tri-Ring device to treat TR
Cardiac Implants has announced the successful initial deployment of its annuloplasty ring with imple...
Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB
Concept Medical has announced the successful completion of the TRANSFORM 1 RCT. The randomised c...
TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude
A budget impact analysis comparing transcatheter aortic valve implantation (TAVI) with surgical ...
Vascade vascular and venous closure devices gain CE mark
Haemonetics Corporation has received CE mark certification for its Vascade vascular closure and ...
Latest Sapien TAVI valve features anti-calcification technology
Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valve—combining Edwards’...
Three-year data “reinforce safety and efficacy” of Abbott’s Amplatzer Piccolo in infants with PDA
Abbott has announced three-year data for its Amplatzer Piccolo occluder for the treatment of patent ...
The time for change is now: Call for action over “ageing and unbalanced” cardiothoracic surgery community
Analysis of the global make-up of the four largest global societies for cardiothoracic surgery sugge...
Results of cuffless blood pressure monitor presented at AHA Hypertension Sessions
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring system are being presente...
First patient joins study of SSO2 therapy post-PCI
Zoll Medical has announced that the first patient has been enrolled in the AMIHOT III post-approval ...
Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe
Abbott has announced the European launch of its Amplatzer Talisman patent foramen ovale (PFO) occlus...
AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal AF
AtriAN Medical has announced that it has completed enrolment of a second study using its selective p...
Tom Nguyen
As a proponent of minimally invasive cardiac surgery and transcatheter techniques, Tom Nguyen (Unive...
Cardiovascular News’ top 10 most popular stories of August 2022
The most read stories from across Cardiovascular News in August 2022 include highlights from the Eur...
FDA clears Viz.ai’s right-to-left ventricle ratio algorithm
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ve...
Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter
Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular Institute (Miami, USA...
New DAPT labelling approved for Watchman FLX device
Boston Scientific has received US Food and Drug Administration (FDA) approval to expand the inst...
First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD
Cardionovum has announced the enrolment of the first patient in the international Hyper II clini...
JenaValve raises US$100 Million to advance Trilogy TAVI system
JenaValve Technology has announced that it has completed the initial closing of a US$100 million Ser...
ESC 2022: Risk score predicts mortality for AF patients after TAVI
Researchers have developed a risk score to predict mortality for patients with atrial fibrillati...
ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD
Abbott has announced the release of late-breaking showing that its HeartMate 3 heart pump extend...
ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures
Transradial access for percutaneous coronary procedures is associated with lower rates of all-ca...
ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI
Fifteen-month results from the MASTER DAPT trial have shown that the preserved ischaemic benefit...
ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach
In patients with advanced chronic kidney disease (CKD) and chronic coronary disease, an invasive...
ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI
Selection of non-infarct related artery (IRA) lesions for intervention using fractional flow res...
ESC 2022: High-risk aortic stenosis could be picked up using AI
Late-breaking research presented at the European Society of Cardiology (ESC) annual congress (26...
ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients
Among high-risk patients undergoing percutaneous coronary intervention (PCI), a follow-up strate...
ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT
Results of one of the first and only randomised, blinded trials to assess the use of an artifici...
ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ho...
ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care
Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill containing an antiplatel...
ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes
The timing of dosing of antihypertensive medication—whether it is taken in the morning or in the...
Programme released for TCT MedTech Innovation Forum
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the programme...
Medtronic launches Onyx Frontier coronary stent following CE mark approval
Medtronic has announced the launch of its latest generation drug-eluting coronary stent—Onyx Frontie...
Cardiovascular News 66 – August 2022: OUS Edition
In this issue:
Call for action over age and gender profile of global cardiothoracic surgery com...
Cardiovascular News 66 – August 2022: US Edition
In this issue:
Call for action over age and gender profile of global cardiothoracic surgery com...
Miracor’s PiCSO technology approved by FDA for investigational device exemption study
Miracor Medical has announced the approval of an investigational device exemption (IDE) from the...
First-in-human procedure completed using ShortCut Mitral device
Pi-Cardia has announced a successful first-in-human treatment of the mitral valve with the ShortCut ...
Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation
Edwards Lifesciences has announced that the company's Pascal Precision transcatheter valve repai...
Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella
Abiomed has announced the results of the Restore EF study, demonstrating that Impella-supported hig...
CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (24–26 October, Digital), bringing togethe...
AHA and CRF announce collaborative education programme
The American Heart Association (Association) and the Cardiovascular Research Foundation (CRF) have a...
Spotlight turns to TAVI in patients with moderate aortic stenosis
Ongoing clinical trials looking at transcatheter aortic valve implantation (TAVI) for patients w...
Cardiovascular News’ top 10 most popular stories of July 2022
The most read stories from across Cardiovascular News in July 2022 include reflections on the future...
“Worrisome” rise in cardiovascular disease predicted out to 2060
Projected rates of cardiovascular risk factors and disease will increase significantly in the USA by...
“Positive” 30-day outcomes for patients receiving Optimum transcatheter aortic valve
Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two patients receiving ...
Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine
Cardiac surgeons from North America, Europe and Latin America are among the signatories to a multidi...
Genetic “cure” for cardiomyopathy is selected as winner of Big Beat Challenge
A project to develop genetic therapies to effectively cure cardiomyopathy has been announced as ...
Three-year results of RANGO registry presented at EuroPCR
iVascular has announced the release of three-year observational data concerning its Angiolite cobalt...
Neovasc gains approval for protocol supplement to COSIRA-II trial
Neovasc has announced that the US Food and Drug Administration (FDA) has approved a protocol sup...
Digital drainage system for cardiac surgery “safe and effective”
Centese has announced the publication of the first peer-reviewed clinical study of its Thoraguard di...
Pi-Cardia gains FDA nod for study of ShortCut leaflet splitting device
Pi-Cardia has received Investigational Device Exemption (IDE) approval from the US Food and Drug Adm...
Ultrasound renal denervation meets primary efficacy endpoint in RADIANCE II study
ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US Food and Drug Admini...
Steps needed to include disadvantaged patients in mitral and tricuspid trials
Incentives for the enrolment of patients from socieconomically disadvantaged groups, as well as ...
Cathbot completes enrolment in clinical study of robotic-assisted PCI in China
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last patient in its clinical...
Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI
Preventing coronary obstruction after transcatheter aortic valve implantation (TAVI) becomes inc...
New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers
A research project at the University of Leeds (Leeds, UK) aiming to find an easier way to establ...
FDA grants breakthrough status for Accucinch ventricular restoration system
Ancora Heart has announced that the US Food and Drug Administration (FDA) has granted Breakthrou...
First patients enrolled in study of Booster spiral balloon therapy for acute myocardial infarction
Intratech Medical has announced the successful enrolment of two patients in a multicentre first-in-h...
VenusP-Valve gains approval from China’s NMPA
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (TPVR) system has been...
Stress testing can guide patient selection for coronary revascularisation
Patients identified by nuclear stress testing as having severe stress-induced myocardial ischaem...
Echocardiographers face “under-recognised” radiation exposure risk in the cath lab
Echocardiographers may be at significantly greater risk of exposure to radiation than interventional...
TCT MedTech Innovation Forum to spotlight opportunities for innovation
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the launch of the...
Analysis shows “positive trend” with thinner strut stents in patients with small vessels
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards better outcomes” with thi...
HeartBeam expands software platform to cover unstable angina
HeartBeam is expanding the available patient population for its emergency department software techno...
Cardiovascular News’ top 10 most popular news stories of June 2022
The most read stories from across Cardiovascular News in June 2022 include highlights from TVT 2022 ...
Female representation in interventional cardiology remains low, but there is cause for hope
Suzanne Baron and Ki Park detail some of the barriers facing women in the field of interventiona...
Advanced NanoTherapies closes Series A funding round
Advanced NanoTherapies has closed a US$7.2 million Series A equity financing round marking a tot...
EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients
Results from the first commercial implants of the Trilogy transcatheter aortic valve implantatio...
First patients enrolled in Manta Ultra vascular closure device study
Teleflex has announced the first patient enrolment in a clinical study that is intended to demon...
AF after surgery is linked to an increased risk of heart failure hospitalisation
People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted...
Acutus launches expanded suite of left-heart access products
Acutus Medical has announced the commercial launch of an expanded suite of left-heart access pro...
CABG “associated with favourable outcomes and increased long-term survival” among octogenarians
A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochester, USA) has found t...
CONFORM pivotal trial of CLAAS system begins enrolment
Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of th...
TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman...
TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston Scientific) device ...
TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip treatment in secondar...
TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”
Data from the first report on patients with a pacemaker lead across the tricuspid valve have sho...
First patient treated in HEAL-IST clinical trial
AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the...
Patients with mitral annulus calcification at higher risk of mitral valve dysfunction
A retrospective review of more than 24,000 patients who underwent an electrocardiogram (ECG) has fou...
First-in-human results of Captis embolic protection device presented at EuroPCR 2022
Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safe...
Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care
A study has revealed the “global collateral damage” caused by the disruption to cardiac services cau...
UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior to surgery for all-c...
EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies
The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...
AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD) implantation did n...
SCAI 2022: Analysis looks at coronary IVL outcomes in women and men
New data confirming one-year outcomes with coronary intravascular lithotripsy (IVL, Shockwave Me...
SCAI names Sunil Rao as incoming president
Sunil Rao (Duke University Health System, Durham, USA) has assumed the office of president of th...
Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial
Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of...
EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Edwards Lifesciences) ...
EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique
Use of the cusp overlap technique for the deployment of devices in transcatheter aortic valve im...
EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety
Results of the 20-patient, first-in-human clinical study supporting the safety and efficacy of the S...
EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed
Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...
SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”
Analysis of data from a US-wide health system suggests that the volume of percutaneous coronary inte...
Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, France) focused on th...
EuroPCR 2022 hears new data on robotic PCI
New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...
EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...
EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France) underscore the pot...
Medtronic gains FDA approval for Onyx Frontier drug-eluting stent
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for the ...
Cardiovascular News 65 – May 2022: US Edition
In this issue:
New data hint at positive performance of TAVI on structural valve durability
...
Cardiovascular News 65 – May 2022: OUS Edition
In this issue:
New data hint at positive performance of TAVI on structural valve durability
...
Analysis charts “significant” growth of US TEER procedures since 2012
A US analysis comparing trends in transcatheter and surgical mitral valve repair (SMVR) has found a ...
Abbott funds programme to boost diversity in clinical trial leadership
Abbott has announced a new partnership with Women as One to launch a new programme designed to train...
Vijay Kunadian
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastl...
ADVERTORIAL: Cath lab technologies for medicine in the precision age
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab, having a suite of t...
ADVERTORIAL: TAVI valve durability under the microscope
This advertorial is sponsored by Medtronic
Due to the growth of transcatheter aortic valve im...
Cardiovascular News’ top 10 most popular stories of April 2022
The most read stories from across Cardiovascular News in April 2022 include highlights and late-brea...
DCB in PCI: Adjunctive therapy or standard of care?
This educational supplement, sponsored by Medtronic, explores the science underpinning the use of dr...
“TAVI was my baby, now it is a teenager”
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 is a landmark date, ...
Health Canada approval granted for SavvyWire TAVI guidewire
OpSens has announced that it has received Health Canada approval for the SavvyWire, its new guidewir...
Japanese and US regulatory approvals granted for BioFreedom stent
Biosensors International Group has announced both the Japanese Pharmaceuticals and Medical Devic...
First patient enrolled in EXPAND TAVR II trial
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pivotal trial, the fir...
SCAI issues position paper on transaxillary arterial access
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...
Translumina announces launch of dual drug polymer-free coated stent
Translumina has announced the launch of Vivo Isar, its latest generation dual drug polymer-free coat...
“Hybrid” model likely to be a hallmark of the post-pandemic era for heart failure care
The pandemic saw a boom in the use of remote technologies and telehealth for patient monitoring ...
FDA approves coronary use of XO Cross support catheter system
Transit Scientific has announced US Food and Drug Administration (FDA) clearance of its XO Cross...
Quest International and CathWorks partner to scale up FFRangio
Quest International and CathWorks have announced a strategic partnership. Quest has been selecte...
VenusP-Valve gains CE mark
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—VenusP-Valve—has received...
CeloNova to seek medical device partnerships
CeloNova BioSciences has announced the strategic decision to focus its core business on creating...
ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT
Patients treated with edoxaban for six months after a transcatheter aortic valve implantation (T...
Cardiovascular News’ top 10 most popular stories of March 2022
The most read stories from across Cardiovascular News in March 2022 include a wealth of late-breakin...
FEops Heartguide receives FDA clearance for LAAO planning capabilities
FEops has announced that it received authorisation from the US Food and Drug Administration (FDA...
First patient in Japan treated with Impella 5.5 with SmartAssist
Abiomed has announced that the first patient in Japan has been treated successfully with Impella...
First patient enrolled in BIOMICS study for CTO-PCI
Biosensors International has announced the enrolment of the first patient in the BIOMICS study, a pr...
ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years
Patients who received a transcatheter supra-annular self-expanding heart valve had less structural d...
ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19
Latest results from the North American COVID-19 STEMI (NACMI) registry reported a 25% reduction ...
ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ultrasound (IVUS) guide...
ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation
Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have been presented during ...
ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial
Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter valve (Edwards Lifesc...
Corvia announces publication of REDUCE LAP-HF II data
Corvia Medical has announced publication of analyses from its global, phase III REDUCE LAP-HF II...
ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) leads to a fast...
SafeCross transseptal balloon gets first commercial use
East End Medical has announced the first commercial use of its SafeCross transseptal radiofreque...
Philips launches Ultrasound Workspace at ACC.22
Royal Philips is launching an echocardiography image analysis and reporting solution—Ultrasound Work...
SCAI aims to minimise risks in medical proctoring of new techniques and technologies
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...
FDA approval granted for Mitris Resilia mitral valve replacement
Edwards Lifesciences has announced it received approval from the US Food and Drug Administration (FD...
Shockwave coronary IVL gains Japanese approval
Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has received regulatory app...
First patient enrolled in PICSO-AMI-V study
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V study to evaluate Pi...
RADIANCE-II renal denervation trial completes enrolment
Investigators have completed enrolment in the RADIANCE-II pivotal trial of the Paradise ultrasound r...
Carmat sets date for resumption of implants of artificial heart system
Carmat, designer and developer of an advanced total artificial heart, has issued an update on it...
Deep learning tool could predict future myocardial infarction
Researchers have detailed the use of an artificial intelligence-enabled tool for atherosclerotic...
First-in-human study paves way for further clinical trials of Valvosoft
Cardiawave has announced the success of its first-in-human I (FIH I) safety and feasibility clinical...
Expert group sets out principles for device-led hypertension trials
A consensus document outlining design principles and outcome definitions for device-based therapies ...
Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system
Four radial cases using the PH Band System (Medical Ingenuities)—a novel medical device that is ...
Venus Medtech targets European growth with senior appointment
Venus Medtech has appointed Shakeel Osman as senior vice president of sales Europe, responsible for ...
Women less likely to receive cardiogenic shock treatment
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to r...
Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients
Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one ye...
Putting “stent regret” behind us
Nick West, chief medical officer and divisional vice president of Global Medical Affairs, Abbott...
Xeltis announces “promising outcomes” in restorative graft trials following EU financing
Xeltis has announced promising initial outcomes from two key vascular trials involving its restorati...
ACC issues clinical guidance on cardiovascular consequences of COVID-19
The American College of Cardiology (ACC) has issued an expert consensus decision pathway for the eva...
CSI’s Propel pVAD system gets first-in-human use
Cardiovascular Systems—CSI—has announced the first in-human experience with Propel, its first-genera...
First patient treated in study of PerQseal+ vessel closure device
Vivasure Medical has announced today that the first patient was treated in a US early feasibilit...
Cardiologists without borders
“When I was one year old, my father died in the war between Israel and Egypt and I was left with...
Ryan Egeland joins Big Sky Biomedical
Big Sky Biomedical has appointed Ryan Egeland as managing director.
“Big Sky Biomedical was f...
Medtronic expands reach of AI-powered surgical video management and analytics platform
Medtronic has announced that it has entered into a contract with Vizient to add Touch Surgery En...
Cardiovascular News’ top 10 most popular stories of February 2022
The most read stories from across Cardiovascular News in February 2022 include training for robotic ...
CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical outcomes after transcat...
CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition
A novel transcatheter system designed for transfemoral mitral valve repair—the NeoChord Nexus sy...
CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...
CRT 2022: Four-year LRT data “support TAVI in low-risk patients”
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...
VISION study concludes troponin is a benchmark for cardiac surgery risk
Levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased r...
Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed
Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Michael Haude (Rheinla...
CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX
Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientif...
Women underrepresented in cardiovascular clinical trial leadership positions
Women remain underrepresented in leading cardiovascular clinical trials, corresponding with unde...
CRT 2022 hears results of animal study of Tria TAVI valve
Results from the first animal study of the Tria transcatheter aortic valve (Foldax) have been pr...
CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...
Partnership to promote wearable tech in cardiology trials
Wearable technology and digital health specialist Activinsights has announced a partnership agreemen...
High coronary artery calcium score increases risk of heart attack or stroke
Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a mor...
CX 2022 returns to in-person format facing challenges and opportunities in the aortic field
Anticipation is building for the Charing Cross International Symposium 2022 (CX 2022). This will...
Teleflex catheters and coronary guidewires cleared for CTO PCI
Teleflex has announced that the US Food and Drug Administration (FDA) has cleared an expanded indica...
New data underpin drive towards earlier AF ablation strategies
Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have...
Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality
Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospi...
Siemens introduces “integrated” cath lab imaging system, Artis icono biplane
Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with dete...
Ross procedure “associated with better long-term outcomes” for aortic valve replacement
The “Ross procedure” may be a more favourable option for aortic valve replacement among patients...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indicat...
On-pump and off-pump CABG confer similar outcomes over 10 years
A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary artery bypass graftin...
Heart team approach points to mortality benefit in complex cardiac patients
Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective...
New technique outperforms manual assessment of thoracic aortic aneurysm growth
Researchers have developed a novel method of measuring growth of thoracic aortic aneurysm, which the...
Robert Califf to return as US FDA commissioner
Cardiologist and researcher Robert Califf has been confirmed as the commissioner of the US Food ...
Expanded robotic training will benefit cardiovascular care
Robotic systems have the potential to fundamentally change the way care is delivered to patients in ...
3D printing to support physician training and coronary device testing
The donation of new 3D printing technology to the Visible Heart Laboratories at the University o...
Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant
Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...
Boston Scientific closes acquisition of Baylis Medical Company
Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a compan...
MedHub announces investment and pivotal study completion
MedHub has announced the completion of a funding round worth US$1 million in new financing, alongsid...
Supreme drug-eluting stent “safe and effective” in complex coronary lesions
The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and safe at one year acro...
Portsmouth Hospital: How tech is guiding decision-making in the cath lab
Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) documents how computer-der...
HeartFlow and Longview terminate merger agreement
HeartFlow has announced that it and Longview Acquisition Corporation have mutually agreed to termina...
Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events
Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adv...
IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation
The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long ...
Cardiovascular News’ top 10 most popular stories of January 2022
The most read stories from across Cardiovascular News in January 2022 include controversy surroundin...
Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool
Acarix has submitted a breakthrough designation request for its technology for heart failure diagnos...
“Game changing” photon-counting CT system arrives at John Radcliffe Hospital
The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxfor...
Philips expands haemodynamic assessment in its Lumify handheld ultrasound system
Royal Philips has announced an update to its handheld ultrasound platform—Lumify—adding Pulse Wave D...
Second phase of ASCENT ASD trial begins
Atheart Medical has announced that it has received US Food and Drug Administration (FDA) approva...
Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial
The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not ...
First patient enrolled in RISE SC study of coronary balloon
Biosensors has announced the enrolment of the first patient in the RISE SC study, a single arm, pros...
Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment
BioCardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Devi...
CroíValve completes funding round for study of Duo system
CroíValve has raised a Series A round to fund a feasibility clinical study with its Duo Coaptati...
SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the release ...
Abbott’s Nick West points to future role of AI in the cath lab
Abbott has released a second round of insights from its Beyond Intervention global research prog...
ADVERTORIAL: Fresh data paint a positive picture for IVL in both eccentric and nodular coronary calcium
This advertorial is sponsored by Shockwave Medical.
The latest data from the Disrupt CAD clinical...
ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generation of self-expandin...
Susheel Kodali
Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in New York, where he ...
Cardiovascular News 64 – February 2022: US Edition
In this issue:
Coronary revascularisation guidelines spark debate
New data on IVL in eccent...
Cardiovascular News 64 – February 2022: OUS Edition
In this issue:
Coronary revascularisation guidelines spark debate
New data on IVL in eccent...
STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery
Insights from what was described as the “largest and most comprehensive” analysis of isolated su...
PROACT clinical trial results published for On-X mechanical mitral valve
Artivion has announced the publication of PROACT clinical trial results in The Annals of Thoracic Su...
SCAI issues updated expert consensus statement on cardiogenic shock
The Society for Cardiovascular Angiography and Interventions (SCAI) has released its updated exp...
STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president
Cardiothoracic surgeon John H Calhoon from The University of Texas Health Science Center (UT Hea...
STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery
Patients with mitral valve disease who live in disadvantaged communities are more likely to expe...
InnovHeart completes funding round to advance Saturn TMVR system
InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatme...
JIM 2022 moves to June slot
Organisers of the Joint Interventional Meeting (JIM) have announced that the 2022 edition of the eve...
First patient enrolled in TRANSFORM II study of sirolimus-coated balloon
The first patient has been enrolled in the TRANSFORM II randomised controlled trial assessing th...
“Considerable” reduction in PCI-related radiation reported in last decade
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “considerably” during ...
Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn
Researchers have warned that the number of people suffering from aortic valve stenosis in the UK cou...
Grant funding for 3D-printed paediatric heart models
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant Scheme, run by NHS me...
Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection
New clinical practice guidelines have been published today, and are intended to act as “guard rails”...
Scoreflex NC PTCA catheter gains FDA premarket approval
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Food and Drug Administ...
Gore’s Cardioform Septal Occluder reaches 10-year milestone
WL Gore & Associates has announced that its Cardioform Septal Occluder has achieved 10 years...
Young surgeons to benefit from Transatlantic grant scheme
In a joint programme between the Society of Thoracic Surgeons (STS) and the European Association...
TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients
A propensity score-matched analysis of the early outcomes of transcatheter aortic valve implantation...
Pioneering pig to human heart transplant heralded as a breakthrough
A 57-year-old patient with terminal heart disease received a successful transplant of a genetically-...
AATS and STS opt not to endorse joint coronary revascularisation guidelines
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) have...
Omicron surge sees STS move 2022 annual meeting online
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an in-person to a virt...
Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines
Terumo Medical Corporation has welcomed the publication of updated guidelines from the American Coll...
Robocath completes European study of robot-assisted PCI
Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed a...
Impella gains a trio of regulatory approvals
Regulators in three countries have granted approvals to Impella surgical products. In the USA, the F...
Evolut PRO TAVI valve gains approval in China
Medtronic has announced that the National Medical Products Administration (NMPA) has approved th...
Cardiovascular News’ top 10 most popular stories of December 2021
The most read stories from December 2021 include analysis of the CHEETAH study and the role of mecha...
First patient enrolled in COSIRA-II trial of Neovasc Reducer
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical trial.
COSIRA-II (...
Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change
Endotronix has announced that the US Food and Drug Administration (FDA) has granted approval for...
Partnership to develop training system for complex valve-in-valve procedures
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partnering to develop a ne...
FDA clears CavaClear IVC filter removal laser sheath
Royal Philips has announced US Food and Drug Administration (FDA) de novo clearance for the Phil...
First clinical results for Tria biopolymer valve published
Foldax has announced publication of the first clinical results for its Tria biopolymer heart val...
Sapien 3 with Alterra prestent gains FDA approval
Edwards Lifesciences has received approval from the US Food and Drug Administration (FDA) for th...
Research suggests many patients may be safely discharged without opioids after cardiac surgery
Many patients undergoing cardiac surgery may be able to safely and effectively control postoperative...
EMPAKT CHF trial points to change in assessment acute heart failure patients
FAST BioMedical has announced the publication of additional results from the EMPAKT CHF (Estimating ...
Initial implants of Thubrikar TAVI system to commence
Thubrikar Aortic Valve has received approval from a Competent Authority in Poland to conduct initial...
AI improves confidence in CAD detection from a stress echocardiogram
Ultromics has announced the publication of a study assessing its EchoGo platform, powered by Art...
HeartFlow submits premarket application for coronary plaque assessment
HeartFlow has announced it has submitted a 510(k) premarket application to the US Food and Drug Admi...
“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI
Results of the CHEETAH clinical study highlight the potential role of mechanical aspiration thro...
Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX
Svelte Medical Systems has received US Food and Drug Administration (FDA) approval to commercialise ...
Opsens files 510(k) submission to US FDA for TAVI guidewire
Opsens has filed a 510(k) submission with the US Food & Drug Administration (FDA) for regulatory...
Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the Department of Cardi...
Understanding the risk of acute kidney injury in the cath lab
Huge strides have been made in preventing contrast-associated acute kidney injury among patients...
Heart team approach central to updated coronary revascularisation guidelines
New guidelines for coronary artery revascularisation recommend that treatment decisions should be ba...
Coronary artery modelling technology enables 3D reconstruction of coronary vasculature
RSIP Vision has announced a new coronary artery modelling technology, which enables reconstruction o...
Philips expands cardiac ultrasound portfolio
Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and ...
Foldax commences clinical study of Tria surgical aortic valve in India
Foldax has announced that the Drugs Controller General of India (DCGI), India’s regulatory body for ...
Venus Medtech announces Cardiovalve acquisition
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitral and tricuspid val...
SyMap Medical closes US$100 million financing round
SyMap Medical has announced the completion of a financing round which will be used to accelerate...
Restore Medical announces preliminary results from first-in-human use of ContraBand
Restore Medical has announced preliminary results of the first-in-human clinical trial of ContraBand...
Survey: Bullying “commonly experienced” by UK cardiology trainees
One in 10 junior doctors training to be cardiologists in the UK say they have been bullied, the resu...
Interim REVERSE-IT trial results published in NEJM Evidence
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceuticals), which is de...
Cardiovascular News’ top 10 most popular stories of November 2021
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 N...
AI-based algorithm could predict outcomes after cardiac surgery
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunction from a single-l...
Soundbite Medical gains fifth US patent for its plaque modification technology
Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a paten...
Robocath announces completion of first robotic coronary angioplasty with R-One in China
Robocath has announced the successful completion of what it has described as the first coronary angi...
TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation
Findings of the CHOICE MI registry show that transcatheter mitral valve implantation (TMVI) is a...
PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, presented...
Mirvat Alasnag
Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Currently the director...
CSI recalls Wirion embolic protection device
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems ...
PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion
Two-year findings of a post-hoc study from the GALILEO trial, investigating the clinical outcome...
PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation
First clinical results of transcatheter aortic valve implantation (TAVI) using the Jenavalve sys...
PCR London Valves hears first results from NeoChord Nexus mitral repair device
The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system f...
First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire
Opsens has announced the successful treatment of 20 patients leading to the completion of the first ...
First patients enrolled in FAST III study of vFFR-guided PCI
The first patients have been enrolled in the FAST III trial at the Erasmus University Medical Center...
ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease
European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular dis...
SCAI pushes revised standardised language to improve cardiogenic shock care
New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standar...
Findings of meta-analysis “move the conversation forward” on left main revascularisation
A meta-analysis comparing percutaneous coronary intervention (PCI) using a drug-eluting stent (D...
AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI
An updated risk score to predict possible contrast-associated acute kidney injury (CA-AKI) among...
AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG
Use of a novel, venous external support device (VEST, Vascular Graft Solutions) may lead to incr...
HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance to deliver its AI-ass...
AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation
Coronary artery bypass graft sugery (CABG) between two and three days after ticagrelor cessation was...
AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early aortic valve replaceme...
What to expect from AHA 2021
Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2021, 13–15 November,...
ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab
This advertorial is sponsored by iVascular
Treatment of a chronic total occlusion (CTO)—a complet...
“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021
Early data presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021; ...
Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease
Abbott has released new research from its Beyond Intervention initiative, a multi-year global resear...
Ron Waksman joins SIS Medical AG advisory board
SIS Medical AG has appointed Ron Waksman, associate director Division of Cardiology, MedStar Was...
Lessons from SURTAVI
Transcatheter aortic valve implantation (TAVI) pioneer and principal investigator of the SURTAVI tri...
Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB
Cardiovascular Systems has announced the start of enrolment in a first in-human trial of the coronar...
Patients more likely to survive a cardiac arrest in the operating room than the cath lab
Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospita...
Two-year results of mitral valve repair using ChordArt device published
CoreMedic has announced the publication of two-year follow-up results from the first in-human CHAGAL...
Medtronic announces 2045 net zero emissions ambition to combat climate change
Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across...
TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascular Therapeutics annu...
TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve
Six-month results from the TRISCEND study of the Evoque (Edwards Lifesciences) transcatheter tri...
TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral valve replacement (T...
TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovascular Therapeutics an...
TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens
Patients receiving antiplatelet therapy following percutaneous coronary intervention (PCI) devel...
TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella
The final results of the PROTECT III and Restore EF prospective studies demonstrate improved out...
TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K-antagonists (NOACs)...
TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke
Five-year clinical and echocardiographic outcome data from the SURTAVI randomised trial comparin...
TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI
Results from the largest randomised trial to date comparing different closure device strategies ...
TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds
An economic analysis of data from the PARTNER 3 randomised trial, comparing transcatheter aortic...
TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart
Penumbra has announced that the CHEETAH clinical study of its Indigo system CAT RX catheter succ...
TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravascular lithotripsy (IV...
TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusively in patients wit...
TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation
Randomised placebo-controlled trials show consistently that renal denervation provides significant r...
TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasoun...
TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial
Lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed phys...
TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet no...
Cardiovascular News 63 – November 2021: US Edition
In this issue:
MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT)
...
Cardiovascular News 63 – November 2021: OUS Edition
In this issue:
MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT)
...
TCT 2021: Philips to showcase developments in its interventional portfolio
Royal Philips has previewed updates in its product portfolio and new data due to be shared at the Tr...
Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021
Procyrion has announced the presentation of studies at the Transcatheter Cardiovascular Therapeutics...
Aktiia announces Series A funding round
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series A round of funding t...
ReValve Solutions announces first use of its Palmetto mitral valve replacement system
ReValve Solutions has announced that it has successfully completed the first-in-human use of its tra...
TCT 2021: Studies to highlight patient outcomes with Impella
Results from two studies of the Impella heart pump device will be presented at the Transcatheter Car...
Bifurcation lesions: Exploring the latest science
This educational supplement, sponsored by Medtronic, explores the latest evidence covering the treat...
AHA and ACC release clinical guidelines for evaluation of chest pain
Joint clinical practice guidelines have been issued by the American Heart Association (AHA) and the ...
EACTS speakers question evidence underpinning guidelines for left main revascularisation
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 Octobe...
Longest available real-world follow-up data for Tendyne valve support use of device in select patients
The longest available real-world follow-up data of transcatheter mitral valve implantation (...
Enrolment completed in study of Teleflex QuikClot device
Teleflex announced the completion of patient enrolment in a clinical study evaluating the performanc...
Research finds poor level of surveillance following aortic dissection repair
Patients who survive an aortic dissection often fail to receive comprehensive post-surgical fo...
CRF waives cost for digital access to TCT 2021
The Cardiovascular Research Foundation (CRF) has announced that the digital component of the Transca...
PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent
Sinomed has announced that the PIONEER III clinical trial results for its HT Supreme drug-elutin...
Cardiac CTA parameters predict post-TAVI mortality
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) improves predictive pe...
First European implants of Trilogy TAVI system completed
JenaValve Technology has announced the first commercial implants with the Trilogy heart valve System...
Heartflow announces start of REVEALPLAQUE clinical trial
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate the company’s non-inv...
Study charts “inequities” in growth of TAVI in US hospitals
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred...
Ethnic and racial minority cardiologists face professional discrimination and exclusion
Ethnic and racial minority cardiologists report career satisfaction but face professional discrimina...
EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials
The underrepresentation of women in clinical coronary revascularisation trials may encourage tre...
Clinical study of SavvyWire TAVI guidewire commences
OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and succe...
Next generation of aortic surgeons need open and endovascular skills
Building and maintaining expertise in both open and endovascular surgical techniques will play a...
ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases
ReCor Medical has announced that its Paradise ultrasound renal denervation system is now available f...
Baylis Medical Company to sell its cardiology business to Boston Scientific
Baylis Medical Company has reached an agreement to sell its cardiology business to Boston Scientific...
Philips’ Bert van Meurs discusses the future of imaging in the cath lab
Bert van Meurs is the chief business leader for Image Guided Therapy within Royal Philips, the multi...
NeoChord announces completion of first-in-human case with NeXus TMVr technology
NeoChord has announced successful completion of the first-in-human procedure with the NeoChord NeXuS...
Cardiovascular News’ top 10 most popular stories of September 2021
Top stories for September included more highlights from the European Society of Cardiology’s 2021 co...
Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, USA) have announced ...
FDA monitoring gender differences in outcomes with LAAO devices
The US Food and Drug Administration (FDA) has informed healthcare providers of recent information ab...
Enrolment completed in study of Tria aortic valve
Foldax has announced completion of enrolment in the US early feasibility study of the Tria surgical ...
Siemens launches Luminos Impulse fluoroscopy system
Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, including features such as...
Abbott’s Amplatzer Talisman gains FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Ampla...
Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent
Biotronik has announced that it has received US Food and Drug Administration (FDA) approval of i...
Waiting list mortality for coronary procedures exacerbated during pandemic
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (...
Open Stent Solution closes €2.5 funding round
Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed financing round. The fund...
HRX digital health event moved to September 2022
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital health conference—HRX—h...
Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna
Capturing the latest developments in the comprehensive treatment of aortic disease—from the aortic v...
ADVERTORIAL: Optimising TAVI device choice
This advertorial is sponsored by Medtronic
As transcatheter aortic valve implantation (TAVI) ...
Neovasc to begin COSIRA-II trial of Reducer for refractory angina
Neovasc has announced that it has received Food and Drug Administration (FDA) approval for the inves...
FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s Epic ...
Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients
Patients at low surgical risk who had undergone transcatheter aortic valve implantation (TAVI) f...
Surgical team completes first implant of Aeson bioprosthetic heart in a female patient
A cardiothoracic surgical team with UofL Health–Jewish Hospital and the University of Louisville...
Ultrasound guidance “should be routine” for transfemoral TAVI access
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI) is associated with...
Randomised trials needed to evaluate safety and efficacy of TMVR
Randomised trials are needed to evaluate the safety and effectiveness of transcatheter mitral va...
Abbott receives FDA approval for Portico with FlexNav TAVI system
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's P...
OpSens receives Health Canada approval to begin clinical study of TAVI guidewire
OpSens has announced that it has received Health Canada approval to commence the first in-man study ...
Renal denervation: The most advanced and efficacious interventional approach to treat hypertension
Following the release of the European Society of Hypertension’s (ESH’s) updated position paper o...
Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021
One-year data from preclinical trials of Xeltis restorative coronary artery bypass graft (XABG) show...
TCT 2021: Late-breaking trials programme announced
The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science pr...
ESH position paper highlights renal denervation as a third option for hypertension management
European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented ...
Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system
Peijia Medical has announced the initiation of its multicentre clinical trial for TaurusNXT, the...
Christoph Naber
Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career in interventional car...
New imaging technique has the potential to identify patients at high risk of aortic degeneration
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patien...
CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery
CytoSorbents has filed an investigational device exemption (IDE) application to gain US Food and Dru...
STENTiT makes trio of appointment to its medical advisory board
STENTiT, a medical device company bringing a novel class of regenerative endovascular implants f...
No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months
When a modified surgical technique was used to gently remove sections of leg veins used in coronary ...
ABILITY Diabetes Global enrols thousandth patient
Concept Medical has announced the enrolment of the thousandth patient in ABILITY Diabetes Global (Ra...
Digital app speeds up time to STEMI care
“During a heart attack time is myocardium,” says Annapoorna Kini (New York, USA) discussing the ...
Cannabis use in younger adults linked to increased risk of myocardial infarction
Adults younger than 45 years who reported recently using cannabis were two times more likely to have...
Cardiovascular News’ top 10 most popular stories of August 2021
August’s top 10 features a stark warning over representation of women in clinical trials relating to...
HeartFlow announces enrolment of first three patients in FUSION trial
HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, The Netherlands) have...
ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at the European Society...
ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE trial, a multicentre, h...
ESC 2021: Drones touted as the future of defibrillator delivery
The world’s first feasibility study has found that drones can be used to deliver defibrillators to p...
ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chr...
ESC 2021: Study charts impact of following health advice after a heart attack
Adherence to lifestyle advice and medications could add seven healthy years of life after a heart at...
Second hospital implants Aeson bioprosthetic artificial heart
CARMAT has announced the second centre implanting its bioprosthetic artificial heart, Aeson, in the ...
Medtronic gains FDA approval for its latest-generation TAVI system
Medtronic has announced US Food and Drug Administration (FDA) approval of its newest-generation, sel...
ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks
Young heart attack victims are more likely to be smokers, obese, and have high blood pressure or...
EMPOWER trial to study Carillon mitral contour system
Cardiac Dimensions has announced the launch of the US pivotal study the EMPOWER trial, evaluatin...
Urgent TAVI patients more likely to be readmitted than elective cases
Readmissions within 30 days are more common following urgent, rather than elective, transcathete...
Cardiovascular News 62 – August 2021: OUS Edition
In this issue:
Meta analysis draws out debate on coronary revascularisation
What to expect w...
Cardiovascular News 62 – August 2021: US Edition
In this issue:
Meta analysis draws out debate on coronary revascularisation
What to expect w...
Ten-year outcomes of Yukon DES in diabetic patients published in JAHA
Translumina has announced the publication of 10-year clinical outcome data for its Yukon drug-elutin...
Ultromics completes US$33 million Series B funding round
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has announced that it has rai...
FDA grants breakthrough device designation to Impella ECP
The US Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed...
Algorithm predicts heart failure hospitalisations
Biotronik has announced the results from a new study published in EP Europace this week confirming t...
Sinomed announces the first commercial implantation and European launch of the HT Supreme DES
Sinomed has announced the first commercial implantation of the HT Supreme drug-eluting stent (DE...
App launched to cut time to treatment for STEMI patients
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile application to exped...
Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR
CytoSorbents has been granted a second breakthrough device designation for its DrugSorb-ATR antithro...
Abbott’s Amplatzer Amulet gains US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's ...
Occlutech gains IDE approval for OCCLUFLEX pivotal study
Occlutech Holding has announced the conditional US Food and Drug Administration (FDA) approval of it...
“Virtual contrast agent” could offer benefit in cardiac MRI assessment
An imaging technology developed using artificial intelligence (AI) could become an alternative for l...
Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform
Caption Health has announced that the Centers for Medicare and Medicaid Services (CMS) have appr...
Women underrepresented in cardiovascular clinical trials
Women remain underrepresented in cardiovascular clinical trials despite initiatives to ensure broade...
Realview Imaging gains FDA approval for Holoscope-i system
RealView Imaging has announced that it has received US Food and Drug Administration (FDA) 510(k) cle...
Back in the room: A welcome return to in-person education
With the COVID-19 pandemic having switched virtually all of the major meeting in the cardiovascu...
Cardiovascular News’ top 10 most popular stories of July 2021
Our top 10 stories of July 2021, including: A milestone for coronary balloon angioplasty; highlights...
Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19
The largest analysis of its kind to look at the impact of COVID-19 on adult cardiac surgery volu...
US launch for Abbott’s Ultreon AI-based coronary imaging platform
Abbott has announced that it has received US Food and Drug Administration (FDA) clearance for its la...
Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval
Edwards Lifesciences has announced that it has received regulatory approval from Health Canada for b...
PCI procedures drop by 10% in USA since 2010, research suggests
The USA saw a 10% decline in percutaneous coronary intervention (PCI) procedures between 2010 an...
AngelMed launches its Guardian device in the USA
Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of it...
TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure
An analysis of the rates rehospitalisation and mortality in heart failure patients with secondar...
Medtronic launches Prevail DCB in Europe
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) catheter in Europe follo...
ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB
This advertorial is sponsored by Medtronic
The first case using the Prevail (Medtronic) pacli...
CathWorks FFRangio system receives reimbursement approval in Japan
CathWorks has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has appr...
TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery
Among patients undergoing mitral valve surgery after failed transcatheter edge-to-edge mitral va...
TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings
Clinical and economic results from the 3M TAVR economic study have been presented at TVT 2021 (T...
TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year
Patients with bicuspid aortic stenosis may benefit as much from transcatheter aortic valve impla...
TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX
Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-...
MedAlliance launches Origin balloons for vessel preparation
MedAlliance has launched Origin SC and Origin NC, two high performance balloons for vessel preparati...
Ancora Heart secures US$80 million in financing
Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelera...
HeartFlow announces merger agreement
HeartFlow has entered into a definitive business combination agreement with Longview Acquisition...
First Aeson bioprosthetic artificial heart implanted in USA
Carmat has announced the first implantation of its bioprosthetic artificial heart, Aeson, in the USA...
Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation
Patients undergoing permanent pacemaker implantation after surgical aortic valve replacement (SA...
First patients treated with reSept ASD occluder in IDE trial
atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ...
FDA approval for SafeCross transseptal RF system
East End Medical has announced it has received US Food and Drug Administration (FDA) clearance f...
Cardiovascular societies demand action to combat physician burnout
Global action is needed to improve clinician wellbeing, according to four leading cardiovascular hea...
Xeltis initiates synthetic restorative pulmonary heart valve pivotal trial
Xeltis has announced that it has started a pivotal trial for a synthetic restorative pulmonary valve...
Common cath lab practices under the microscope in AHA review
The American Heart Association (AHA) has published a scientific statement challenging “tradition...
Cardiovascular News’ top 10 most popular stories of June 2021
Our top 10 stories of June 2021, including: Analysis of the data for transcatheter aortic valve impl...
CytoSorbents gains IDE for STAR-T trial to remove ticagrelor during cardiothoracic surgery
CytoSorbents has received approval for its investigational device exemption (IDE) application to con...
Carta Healthcare’s AI software certified for use in CathPCI Registry
Carta Healthcare has announced that it has been certified as a National Cardiovascular Data Registry...
Sinomed partners with NUI Galway for HT Supreme stent trial
Sinomed has announced a partnership with the National University of Ireland Galway (NUI Galway, ...
More experienced TAVI centres “less likely to use heart team approach”
Assessment of patients by both interventional cardiologists and cardiac surgeons prior to transc...
First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter
Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography...
Xience stent receives US FDA approval for short-duration DAPT
Abbott has today announced that its Xience family of stents has received US Food and Drug Admini...
Cardiothoracic surgery guidelines updated to optimise blood management among cardiac patients
Clinical practice guidance released today outline recommendations for reducing blood loss during...
Electroducer raises funding to market its external pacemaker device
Electroducer has announced that it has raised €3 million (US$3.65M) from private investors and Frenc...
Vaccine myocarditis risk “far outweighed” by COVID-19 infection
The risk of heart damage from COVID-19 infection is far greater than that from receiving a dose of t...
Pandemic contributes to worsening heart attack outcomes, study finds
Heart attacks during the COVID-19 pandemic were more likely to result in heart failure compared ...
AngelMed gains FDA approval for enhanced real-time cardiac monitor for ACS events
Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (FDA) approval of the...
One in eight CABG patients readmitted within 30 days, meta-analysis finds
Nearly one in eight coronary artery bypass graft (CABG) patients are readmitted within 30 days o...
Medtronic Canada completes end-to-end remotely-guided TAVI procedure
The first end-to-end remotely guided transcatheter aortic valve implantation (TAVI) procedure us...
Tendyne receives breakthrough designation for MAC patients
Abbott has received Breakthrough Device designation from the US Food and Drug Administration (FD...
Royal Philips announces start of DEFINE GPS study
Royal Philips has announced the official start of the DEFINE GPS study, with the first patient b...
Registry DAPT data “could support clinical trials”
Data captured in the National Cardiovascular Data Registry (NCDR) is similar in quality, depth a...
Long-term study finds QoL improvements in CABG patients despite complications
An investigation into the impact of postoperative complications on long-term quality of life (QoL) a...
Cindy Grines
Cindy Grines is an interventional cardiologist and chief scientific officer of Northside Hospital Ca...
PCI complexity does not influence efficacy of ticagrelor or prasugrel in acute coronary syndrome patients
In patients with acute coronary syndrome treated with percutaneous coronary intervention (PCI), ...
“Rapid increase” in cardiovascular disease-related deaths in Asia
The number of people dying from cardiovascular disease (CVD) in Asia is increasing rapidly, with ove...
Study of CorWave’s LVAD presented at ASAIO annual meeting
CorWave has announced that it has successfully completed the first 90-day preclinical study to evalu...
Circulation publishes special edition dedicated to disparities in cardiovascular medicine
Circulation the flagship journal of the American Heart Association (AHA) has published online its fi...
Shockwave’s coronary IVL device gains TPT payment approval
Shockwave Medical has announced today that the Centers for Medicare & Medicaid Services (CMS) ha...
Delaying CABG after AMI may not improve outcomes
A study looking at the timing of coronary artery bypass grafting (CABG) after the occurrence of acut...
Caution needed for TAVI in younger, low-risk aortic stenosis patients
Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk patients have, so f...
Neurescue’s aortic occlusion device gains US FDA approval
Neurescue has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance ...
Pulmonary artery proportional pulse pressure monitoring could improve survival for heart failure patients
A new physiological measurement of heart function could improve survival for people with heart f...
TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve
Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacement system demonstra...
GE Healthcare and ACC partner to advance AI in cardiology
GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and ...
Medtronic stops sale of its HVAD system
Medtronic is stopping the distribution and sale of the Medtronic HVAD system. This morning, the ...
Targeted healing: A new stent concept that could contribute to shortened DAPT
This advertorial is sponsored by Sinomed
As newer-generation drug-eluting stent (DES) technol...
Cardiovascular News’ top 10 most popular stories of May 2021
Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–20 May, virtual), an...
Physician gender does not impact outcomes in PCI patients
There does not appear to be a relationship between operator and patient gender and outcome in patien...
Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE catheter
Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracard...
LivaNova completes initial divestiture of its heart valve business
LivaNova has successfully completed the initial closing of the divestiture of its heart valve bu...
Female aortic dissection patients presenting later, have higher mortality
Women who experience acute aortic dissection are older, have more advanced disease than men when...
Abiomed acquires breakthrough device company preCARDIA
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options...
Sinomed announces presentation of PIONEER III data at EuroPCR 2021
Sinomed has announced results from the HT Supreme healing-targeted drug-eluting stent (DES), in ...
Patients at high risk of bleeding—A forgotten population in PCI?
There is an increasing understanding of the need for tailored strategies when treating high-bleedin...
COVID-19 puts a spotlight on the need for investment in resources for cardiac surgery
A call for greater investment in surgical facilities in the UK in the wake of the COVID-19 pandemic ...
EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic
Interventional cardiologists from across the globe are joining forces for a campaign reinforcing...
Intravascular lithotripsy: Not an eccentric option for eccentric calcium
This advertorial is sponsored by Shockwave Medical.
Severe coronary artery calcification presents...
MDR comes into effect across EU
The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021).
T...
First-in-human use of Tria biopolymer heart valve completed
Foldax has announced the successful first-in-human use of its biopolymer Tria heart valve in surgica...
First patients treated with Aortix pMCS device
Procyrion has announced the treatment of the first patients in the pilot trial to evaluate the perfo...
EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent
Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting (BP-SES; Orsiro, Bi...
RE-ACCESS study has implications for TAVI valve selection
This advertorial is sponsored by Boston Scientific
In recent years, transcatheter aortic valv...
TricValve transcatheter bicaval valve system receives CE mark
OrbusNeich and P&F Products & Features, under the joint partnership OrbusNeich P&F, have...
EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system
Results of an observational study using optical coherence tomography (OCT) to assess the efficac...
EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold
One-year results of the FUTURE-II study—a randomised trial comparing a thin-strut bioresorbable ...
EuroPCR 2021: Meta-analysis supports elective coronary revascularisation
A meta-analysis of randomised trials comparing a strategy of revascularisation plus medical therapy ...
ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI
Clopidogrel monotherapy produced better outcomes than aspirin for the long-term maintenance of p...
EuroPCR 2021: 10-year DISCOVER-FLOW results back HeartFlow FFRct analysis
HeartFlow has announced new data which indicate that the information provided by the HeartFlow F...
ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as a...
EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients
Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...
EuroPCR 2021: Biotronik touts two-year data from BIOSOLVE-IV registry
Long-term follow-up data from the BIOSOLVE-IV registry, presented at the EuroPCR 2021 meeting (1...
FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool
This advertorial is sponsored by PIE Medical
Findings of the multicentre FAST II clinical tri...
EuroPCR 2021: Registry data show low rates of PVL and PPI for Acurate neo2
Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress (18–20 M...
EuroPCR 2021: Philips shares cardiac imaging and software developments
Royal Philips has announced the European availability of new innovations in its portfolio of solutio...
ZOLL Medical receives FDA IDE approval for ISO Shock study
ZOLL Medical Corporation has announced that the US Food and Drug Administration (FDA) has approv...
Abbott’s Navitor TAVI system receives CE mark
Abbott has announced it has received CE mark for its latest-generation transcatheter aortic valve im...
ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients
Among patients with suspected acute coronary syndrome (ACS), the use of a high-sensitivity tropo...
ACC.21: Pandemic has seen burnout “double” among cardiology professionals
The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemi...
ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel disease undergoing percuta...
ACC.21: DAPT de-escalation may benefit AMI patients
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) after 30 days was safe...
ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device ...
ACC.21: Apixaban not superior to standard of care following TAVI
Apixaban was not superior to standard of care following transcatheter aortic valve implantation ...
ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention in AF patients
Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much le...
COBRA PzF stent demonstrates long-term safety at five years post-PCI
CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achieved exceptional lon...
Philips adds haemodynamic measurement to Azurion image-guided platform
Royal Philips has announced the integration of its Interventional Hemodynamic system and portable pa...
Leaflex: Changing the conversation around aortic stenosis?
This advertorial is sponsored by Pi-Cardia
As more transcatheter aortic valve implantation (TAVI)...
Preventing kidney damage in the cath lab
This advertorial is sponsored by Osprey Medical
There is a growing recognition of the risk of con...
Hostile environment: Cardiologists report high prevalence of discrimination and harassment in the workplace
Discrimination and harassment are a common experience among those working in cardiology, according t...
Cardiovascular News 61 – May 2021: OUS Edition
In this issue:
Hostile environment: How cardiologists feel about discrimination in the workplac...
Cardiovascular News 61 – May 2021: US Edition
In this issue:
Hostile environment: How cardiologists feel about discrimination in the wo...
Study shows increasing diversity among US cardiothoracic surgery residents
Research presented at the American Association for Thoracic Surgery 101st Annual Meeting (AATS 2021,...
ACC.21: Digital app should replace stent cards as a patient PCI record
Fewer than half (48%) of patients undergoing percutaneous coronary intervention (PCI) still had ...
Cardiology trainees require preparation to adapt to shift towards telemedicine
A significant proportion of cardiology trainees are uncomfortable with using telemedicine and fe...
AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis
Boston Scientific has announced it has initiated the AGENT IDE trial for the Agent drug-coated ballo...
Mild COVID-19 unlikely to lead to lasting heart damage
Mild COVID-19 infection is unlikely to cause lasting damage to the structure or function of the hear...
Abbott initiates trial focusing on twin AF and heart failure treatments
Abbott has announced a new trial focused on improving the treatment for people simultaneously battli...
Cardiovascular News’ top 10 most popular stories of April 2021
Our top 10 stories of April 2021, including: highlights from the Society for Cardiovascular Angiogra...
ACC.21: App speeds up time to PCI for STEMI patients
ST-elevation myocardial infarction (STEMI) patients received percutaneous coronary intervention (PCI...
SCAI names Timothy Henry as president
Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed the office of preside...
Mitral regurgitation patients treated with TEER will require mitral replacement surgery if treatment fails
Patients suffering from severe mitral regurgitation should be carefully screened and counselled befo...
Medtronic’s Evolut PRO+ TAVI system gains CE mark
Medtronic has announced that it has received the CE mark for the Evolut PRO+ transcatheter aorti...
SCAI 2021: ISCHEMIA trial population not reflected in real-world patients
Patients studied in the ISCHEMIA trial, the largest trial to date to compare revascularisation w...
SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”
Robotic-assisted percutaneous coronary intervention (PCI) using the second-generation CorPath GR...
SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients
Analysis of the prospective Fuwai PCI Registry using selection criteria from the TWILIGHT trial, has...
SCAI updates consensus guidelines on cath lab standards
The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus...
SCAI 2021: Research lays bare the impact of the COVID-19 pandemic on STEMI care
Two research papers presented at the Society for Cardiovascular Angiography and Interventions vi...
SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique
Medtronic has announced results from an interim analysis of the first 171 patients (including 71...
Hospitalised COVID-19 patients at risk of developing heart failure
Patients hospitalised with COVID-19 may be at risk of developing heart failure even if they do n...
CE mark for BACE device for functional mitral regurgitation
Phoenix Cardiac Devices has announced that it has received CE mark for its Basal Annuloplasty of the...
CytoSorbents granted US FDA approval for STAR-T trial
CytoSorbents has announced that the US Food and Drug Administration (FDA) has granted conditional ap...